Pathogenesis of Helicobacter pylori infection.
Journal: 2006/August - Clinical Microbiology Reviews
ISSN: 0893-8512
Abstract:
Helicobacter pylori is the first formally recognized bacterial carcinogen and is one of the most successful human pathogens, as over half of the world's population is colonized with this gram-negative bacterium. Unless treated, colonization usually persists lifelong. H. pylori infection represents a key factor in the etiology of various gastrointestinal diseases, ranging from chronic active gastritis without clinical symptoms to peptic ulceration, gastric adenocarcinoma, and gastric mucosa-associated lymphoid tissue lymphoma. Disease outcome is the result of the complex interplay between the host and the bacterium. Host immune gene polymorphisms and gastric acid secretion largely determine the bacterium's ability to colonize a specific gastric niche. Bacterial virulence factors such as the cytotoxin-associated gene pathogenicity island-encoded protein CagA and the vacuolating cytotoxin VacA aid in this colonization of the gastric mucosa and subsequently seem to modulate the host's immune system. This review focuses on the microbiological, clinical, immunological, and biochemical aspects of the pathogenesis of H. pylori.
Relations:
Content
Citations
(502)
References
(700)
Clinical trials
(1)
Diseases
(4)
Chemicals
(1)
Organisms
(5)
Similar articles
Articles by the same authors
Discussion board
Clin Microbiol Rev 19(3): 449-490

Pathogenesis of <em>Helicobacter pylori</em> Infection

Department of Gastroenterology and Hepatology, Erasmus MC—University Medical Center, Rotterdam, The Netherlands
Corresponding author. Mailing address: Department of Gastroenterology and Hepatology, Erasmus MC—University Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. Phone: 31-10-4632982. Fax: 31-10-4632793. E-mail: ln.cmsumsare@sretsuk.g.j.

Abstract

Helicobacter pylori is the first formally recognized bacterial carcinogen and is one of the most successful human pathogens, as over half of the world's population is colonized with this gram-negative bacterium. Unless treated, colonization usually persists lifelong. H. pylori infection represents a key factor in the etiology of various gastrointestinal diseases, ranging from chronic active gastritis without clinical symptoms to peptic ulceration, gastric adenocarcinoma, and gastric mucosa-associated lymphoid tissue lymphoma. Disease outcome is the result of the complex interplay between the host and the bacterium. Host immune gene polymorphisms and gastric acid secretion largely determine the bacterium's ability to colonize a specific gastric niche. Bacterial virulence factors such as the cytotoxin-associated gene pathogenicity island-encoded protein CagA and the vacuolating cytotoxin VacA aid in this colonization of the gastric mucosa and subsequently seem to modulate the host's immune system. This review focuses on the microbiological, clinical, immunological, and biochemical aspects of the pathogenesis of H. pylori.

Abstract

REFERENCES

REFERENCES

References

  • 1. Achtman, M., and SSuerbaum. 2000. Sequence variation in Helicobacter pylori. Trends Microbiol.8:57-58. [[PubMed][Google Scholar]
  • 2. Akada, J. K., M. Shirai, H. Takeuchi, M. Tsuda, and T. Nakazawa. 2000. Identification of the urease operon in Helicobacter pylori and its control by mRNA decay in response to pH. Mol. Microbiol.36:1071-1084. [[PubMed]
  • 3. Akhiani, A. A., J. Pappo, Z. Kabok, K. Schon, W. Gao, L. E. Franzen, and N. Lycke. 2002. Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells. J. Immunol.169:6977-6984. [[PubMed]
  • 4. Akin, O. Y., V. M. Tsou, and A. L. Werner. 1995. Gastrospirillum hominis-associated chronic active gastritis. Pediatr. Pathol. Lab. Med.15:429-435. [[PubMed]
  • 5. Akopyants, N. S., S. W. Clifton, D. Kersulyte, J. E. Crabtree, B. E. Youree, C. A. Reece, N. O. Bukanov, E. S. Drazek, B. A. Roe, and D. E. Berg. 1998. Analyses of the cag pathogenicity island of Helicobacter pylori. Mol. Microbiol.28:37-53. [[PubMed]
  • 6. Akopyants, N. S., K. A. Eaton, and D. E. Berg. 1995. Adaptive mutation and cocolonization during Helicobacter pylori infection of gnotobiotic piglets. Infect. Immun.63:116-121.
  • 7. Reference deleted.
  • 8. Alamuri, P., and R. J. Maier. 2004. Methionine sulphoxide reductase is an important antioxidant enzyme in the gastric pathogen Helicobacter pylori. Mol. Microbiol.53:1397-1406. [[PubMed]
  • 9. Al-Ghoul, L., S. Wessler, T. Hundertmark, S. Kruger, W. Fischer, C. Wunder, R. Haas, A. Roessner, and M. Naumann. 2004. Analysis of the type IV secretion system-dependent cell motility of Helicobacter pylori-infected epithelial cells. Biochem. Biophys. Res. Commun.322:860-866. [[PubMed]
  • 10. Allaker, R. P., K. A. Young, J. M. Hardie, P. Domizio, and N. J. Meadows. 2002. Prevalence of Helicobacter pylori at oral and gastrointestinal sites in children: evidence for possible oral-to-oral transmission. J. Med. Microbiol.51:312-317. [[PubMed]
  • 11. Allen, LA. 2001. The role of the neutrophil and phagocytosis in infection caused by Helicobacter pylori. Curr. Opin. Infect. Dis.14:273-277. [[PubMed][Google Scholar]
  • 12. Allen, P. 2001. What's the story H. pylori? Lancet357:694. [[PubMed]
  • 13. Alm, R. A., J. Bina, B. M. Andrews, P. Doig, R. E. Hancock, and T. J. Trust. 2000. Comparative genomics of Helicobacter pylori: analysis of the outer membrane protein families. Infect. Immun.68:4155-4168.
  • 14. Alm, R. A., L. S. Ling, D. T. Moir, B. L. King, E. D. Brown, P. C. Doig, D. R. Smith, B. Noonan, B. C. Guild, B. L. deJonge, G. Carmel, P. J. Tummino, A. Caruso, M. Uria-Nickelsen, D. M. Mills, C. Ives, R. Gibson, D. Merberg, S. D. Mills, Q. Jiang, D. E. Taylor, G. F. Vovis, and T. J. Trust. 1999. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature397:176-180. [[PubMed]
  • 15. Amedei, A., M. P. Bergman, B. J. Appelmelk, A. Azzurri, M. Benagiano, C. Tamburini, R. van der Zee, J. L. Telford, C. M. Vandenbroucke-Grauls, M. M. D'Elios, and G. Del Prete. 2003. Molecular mimicry between Helicobacter pylori antigens and H+,K+-adenosine triphosphatase in human gastric autoimmunity. J. Exp. Med.198:1147-1156.
  • 16. Ando, T., R. M. Peek, Jr., Y. C. Lee, U. Krishna, K. Kusugami, and M. J. Blaser. 2002. Host cell responses to genotypically similar Helicobacter pylori isolates from United States and Japan. Clin. Diagn. Lab. Immunol.9:167-175.
  • 17. Ando, T., R. M. Peek, D. Pride, S. M. Levine, T. Takata, Y. C. Lee, K. Kusugami, A. van der Ende, E. J. Kuipers, J. G. Kusters, and M. J. Blaser. 2002. Polymorphisms of Helicobacter pylori HP0638 reflect geographic origin and correlate with cagA status. J. Clin. Microbiol.40:239-246.
  • 18. Appelmelk, B. J., S. L. Martin, M. A. Monteiro, C. A. Clayton, A. A. McColm, P. Zheng, T. Verboom, J. J. Maaskant, D. H. van den Eijnden, C. H. Hokke, M. B. Perry, C. M. Vandenbroucke-Grauls, and J. G. Kusters. 1999. Phase variation in Helicobacter pylori lipopolysaccharide due to changes in the lengths of poly(C) tracts in α3-fucosyltransferase genes. Infect. Immun.67:5361-5366.
  • 19. Appelmelk, B. J., M. A. Monteiro, S. L. Martin, A. P. Moran, and C. M. Vandenbroucke-Grauls. 2000. Why Helicobacter pylori has Lewis antigens. Trends Microbiol.8:565-570. [[PubMed]
  • 20. Appelmelk, B. J., R. Negrini, A. P. Moran, and E. J. Kuipers. 1997. Molecular mimicry between Helicobacter pylori and the host. Trends Microbiol.5:70-73. [[PubMed]
  • 21. Appelmelk, B. J., I. van Die, S. J. van Vliet, C. M. Vandenbroucke-Grauls, T. B. Geijtenbeek, and Y. van Kooyk. 2003. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J. Immunol.170:1635-1639. [[PubMed]
  • 22. Argent, R. H., M. Kidd, R. J. Owen, R. J. Thomas, M. C. Limb, and J. C. Atherton. 2004. Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology127:514-523. [[PubMed]
  • 23. Armstrong, J. A., S. H. Wee, C. S. Goodwin, and D. H. Wilson. 1987. Response of Campylobacter pyloridis to antibiotics, bismuth and an acid reducing agent in vitro—an ultrastructural study. J. Med. Microbiol.24:343-350. [[PubMed]
  • 24. Armuzzi, A., F. Cremonini, F. Bartolozzi, F. Canducci, M. Candelli, V. Ojetti, G. Cammarota, M. Anti, A. De Lorenzo, P. Pola, G. Gasbarrini, and A. Gasbarrini. 2001. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment. Pharmacol. Ther.15:163-169. [[PubMed]
  • 25. Armuzzi, A., F. Cremonini, V. Ojetti, F. Bartolozzi, F. Canducci, M. Candelli, L. Santarelli, G. Cammarota, A. De Lorenzo, P. Pola, G. Gasbarrini, and A. Gasbarrini. 2001. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion63:1-7. [[PubMed]
  • 26. Asahi, M., T. Azuma, S. Ito, Y. Ito, H. Suto, Y. Nagai, M. Tsubokawa, Y. Tohyama, S. Maeda, M. Omata, T. Suzuki, and C. Sasakawa. 2000. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J. Exp. Med.191:593-602.
  • 27. Asahi, M., Y. Tanaka, T. Izumi, Y. Ito, H. Naiki, D. Kersulyte, K. Tsujikawa, M. Saito, K. Sada, S. Yanagi, A. Fujikawa, M. Noda, and Y. Itokawa. 2003. Helicobacter pylori CagA containing ITAM-like sequences localized to lipid rafts negatively regulates VacA-induced signaling in vivo. Helicobacter8:1-14. [[PubMed]
  • 28. Aspholm-Hurtig, M., G. Dailide, M. Lahmann, A. Kalia, D. Ilver, N. Roche, S. Vikstrom, R. Sjostrom, S. Linden, A. Backstrom, C. Lundberg, A. Arnqvist, J. Mahdavi, U. J. Nilsson, B. Velapatino, R. H. Gilman, M. Gerhard, T. Alarcon, M. Lopez-Brea, T. Nakazawa, J. G. Fox, P. Correa, M. G. Dominguez-Bello, G. I. Perez-Perez, M. J. Blaser, S. Normark, I. Carlstedt, S. Oscarson, S. Teneberg, D. E. Berg, and T. Boren. 2004. Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science305:519-522. [[PubMed]
  • 29. Atherton, J. C., P. Cao, R. M. Peek, Jr., M. K. Tummuru, M. J. Blaser, and T. L. Cover. 1995. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem.270:17771-17777. [[PubMed]
  • 30. Atherton, J. C., R. M. Peek, K. T. Tham, T. L. Cover, and M. J. Blaser. 1997. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology112:92-99. [[PubMed]
  • 31. Avenaud, P., A. Marais, L. Monteiro, B. Le Bail, P. Bioulac Sage, C. Balabaud, and F. Megraud. 2000. Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma. Cancer89:1431-1439. [[PubMed]
  • 32. Aviles-Jimenez, F., D. P. Letley, G. Gonzalez-Valencia, N. Salama, J. Torres, and J. C. Atherton. 2004. Evolution of the Helicobacter pylori vacuolating cytotoxin in a human stomach. J. Bacteriol.186:5182-5185.
  • 33. Azuma, T., A. Yamakawa, S. Yamazaki, K. Fukuta, M. Ohtani, Y. Ito, M. Dojo, Y. Yamazaki, and M. Kuriyama. 2002. Correlation between variation of the 3′ region of the cagA gene in Helicobacter pylori and disease outcome in Japan. J. Infect. Dis.186:1621-1630. [[PubMed]
  • 34. Backhed, F., B. Rokbi, E. Torstensson, Y. Zhao, C. Nilsson, D. Seguin, S. Normark, A. M. Buchan, and A. Richter-Dahlfors. 2003. Gastric mucosal recognition of Helicobacter pylori is independent of Toll-like receptor 4. J. Infect. Dis.187:829-836. [[PubMed]
  • 35. Backstrom, A., C. Lundberg, D. Kersulyte, D. E. Berg, T. Boren, and A. Arnqvist. 2004. Metastability of Helicobacter pylori bab adhesin genes and dynamics in Lewis b antigen binding. Proc. Natl. Acad. Sci. USA101:16923-16928.
  • 36. Baker, L. M., A. Raudonikiene, P. S. Hoffman, and L. B. Poole. 2001. Essential thioredoxin-dependent peroxiredoxin system from Helicobacter pylori: genetic and kinetic characterization. J. Bacteriol.183:1961-1973.
  • 37. Bamford, J. T. M., R. L. Tilden, J. L. Blankush, and D. E. Gangeness. 1999. Effect of treatment of Helicobacter pylori infection on rosacea. Arch. Dermatol.135:659-663. [[PubMed]
  • 38. Barnard, F. M., M. F. Loughlin, H. P. Fainberg, M. P. Messenger, D. W. Ussery, P. Williams, and P. J. Jenks. 2004. Global regulation of virulence and the stress response by CsrA in the highly adapted human gastric pathogen Helicobacter pylori. Mol. Microbiol.51:15-32. [[PubMed]
  • 39. Bauerfeind, P., R. Garner, B. E. Dunn, and H. L. Mobley. 1997. Synthesis and activity of Helicobacter pylori urease and catalase at low pH. Gut40:25-30.
  • 40. Bauerfeind, P., R. M. Garner, and H. L. T. Mobley. 1996. Allelic exchange mutagenesis of nixA in Helicobacter pylori results in reduced nickel transport and urease activity. Infect. Immun.64:2877-2880.
  • 41. Bayle, D., S. Wangler, T. Weitzenegger, W. Steinhilber, J. Volz, M. Przybylski, K. P. Schafer, G. Sachs, and K. Melchers. 1998. Properties of the P-type ATPases encoded by the copAP operons of Helicobacter pylori and Helicobacter felis. J. Bacteriol.180:317-329.
  • 42. Beales, I. L. P., J. E. Crabtree, D. Scunes, A. Covacci, and J. Calam. 1996. Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection. Eur. J. Gastroenterol. Hepatol.8:645-649. [[PubMed]
  • 43. Beckwith, C. S., D. J. McGee, H. L. Mobley, and L. K. Riley. 2001. Cloning, expression, and catalytic activity of Helicobacter hepaticus urease. Infect. Immun.69:5914-5920.
  • 44. Beier, D., G. Spohn, R. Rappuoli, and V. Scarlato. 1997. Identification and characterization of an operon of Helicobacter pylori that is involved in motility and stress adaptation. J. Bacteriol.179:4676-4683.
  • 45. Belzer, C., J. Stoof, C. S. Beckwith, E. J. Kuipers, J. G. Kusters, and A. H. M. van Vliet. 2005. Differential regulation of urease activity in Helicobacter hepaticus and Helicobacter pylori. Microbiology151:3989-3995. [[PubMed]
  • 46. Benoit, S., and R. J. Maier. 2003. Dependence of Helicobacter pylori urease activity on the nickel-sequestering ability of the UreE accessory protein. J. Bacteriol.185:4787-4795.
  • 47. Bereswill, S., S. Greiner, A. H. M. van Vliet, B. Waidner, F. Fassbinder, E. Schiltz, J. G. Kusters, and M. Kist. 2000. Regulation of ferritin-mediated cytoplasmic iron storage by the ferric uptake regulator homolog (Fur) of Helicobacter pylori. J. Bacteriol.182:5948-5953.
  • 48. Bereswill, S., U. Waidner, S. Odenbreit, F. Lichte, F. Fassbinder, G. Bode, and M. Kist. 1998. Structural, functional and mutational analysis of the pfr gene encoding a ferritin from Helicobacter pylori. Microbiology144:2505-2516. [[PubMed]
  • 49. Berg, D. E., P. S. Hoffman, B. J. Appelmelk, and J. G. Kusters. 1997. The Helicobacter pylori genome sequence: genetic factors for long life in the gastric mucosa. Trends Microbiol.5:468-474. [[PubMed]
  • 50. Bergman, M. P., A. Engering, H. H. Smits, S. J. van Vliet, A. A. van Bodegraven, H. P. Wirth, M. L. Kapsenberg, C. M. Vandenbroucke-Grauls, Y. van Kooyk, and B. J. Appelmelk. 2004. Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J. Exp. Med.200:979-990.
  • 51. Bergman, M. P., C. M. Vandenbroucke-Grauls, B. J. Appelmelk, M. M. D'Elios, A. Amedei, A. Azzurri, M. Benagiano, and G. Del Prete. 2005. The story so far: Helicobacter pylori and gastric autoimmunity. Int. Rev. Immunol.24:63-91. [[PubMed]
  • 52. Betten, A., J. Bylund, T. Cristophe, F. Boulay, A. Romero, K. Hellstrand, and C. Dahlgren. 2001. A proinflammatory peptide from Helicobacter pylori activates monocytes to induce lymphocyte dysfunction and apoptosis. J. Clin. Investig.108:1221-1228.
  • 53. Bhattacharyya, A., S. Pathak, S. Datta, S. Chattopadhyay, J. Basu, and M. Kundu. 2002. Mitogen-activated protein kinases and nuclear factor-kappaB regulate Helicobacter pylori-mediated interleukin-8 release from macrophages. Biochem. J.368:121-129.
  • 54. Bijlsma, J. J., A. L. M. Lie, I. C. Nootenboom, C. M. Vandenbroucke-Grauls, and J. G. Kusters. 2000. Identification of loci essential for the growth of Helicobacter pylori under acidic conditions. J. Infect. Dis.182:1566-1569. [[PubMed]
  • 55. Bijlsma, J. J. E., B. Waidner, A. H. M. van Vliet, N. J. Hughes, S. Hag, S. Bereswill, D. J. Kelly, C. M. J. E. Vandenbroucke-Grauls, M. Kist, and J. G. Kusters. 2002. The ferric uptake regulator (Fur) homologue of Helicobacter pylori is involved in acid resistance. Infect. Immun.70:606-611.
  • 56. Bizzozero, G. 1893. Ueber die schlauchförmigen Drüsen des Magendarmkanals und die Beziehungen ihres Epithels zu dem Oberflächenepithel der Schleimhaut. Dritte mitteilung. Archiv Mikroskopische Anat.43:82-152. [PubMed]
  • 57. Blaser, M. J., and J. C. Atherton. 2004. Helicobacter pylori persistence: biology and disease. J. Clin. Investig.113:321-333.
  • 58. Blaser, M. J., and J. E. Crabtree. 1996. CagA and the outcome of Helicobacter pylori infection. Am. J. Clin. Pathol.106:565-567. [[PubMed]
  • 59. Bliss, C. M., Jr., D. T. Golenbock, S. Keates, J. K. Linevsky, and C. P. Kelly. 1998. Helicobacter pylori lipopolysaccharide binds to CD14 and stimulates release of interleukin-8, epithelial neutrophil-activating peptide 78, and monocyte chemotactic protein 1 by human monocytes. Infect. Immun.66:5357-5363.
  • 60. Bochner, B. R., and M. A. Savageau. 1977. Generalized indicator plate for genetic, metabolic, and taxonomic studies with microorganisms. Appl. Environ. Microbiol.33:434-444.
  • 61. Boncristiano, M., S. R. Paccani, S. Barone, C. Ulivieri, L. Patrussi, D. Ilver, A. Amedei, M. M. D'Elios, J. L. Telford, and C. T. Baldari. 2003. The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. J. Exp. Med.198:1887-1897.
  • 62. Boneca, I. G., H. de Reuse, J. C. Epinat, M. Pupin, A. Labigne, and I. Moszer. 2003. A revised annotation and comparative analysis of Helicobacter pylori genomes. Nucleic Acids Res.31:1704-1714.
  • 63. Boren, T., P. Falk, K. A. Roth, G. Larson, and S. Normark. 1993. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science262:1892-1895. [[PubMed]
  • 64. Bourzac, K. M., and K. Guillemin. 2005. Helicobacter pylori-host cell interactions mediated by type IV secretion. Cell. Microbiol.7:911-919. [[PubMed]
  • 65. Boutin, S. R., Z. Shen, A. B. Rogers, Y. Feng, Z. Ge, S. Xu, T. Sterzenbach, C. Josenhans, D. B. Schauer, S. Suerbaum, and J. G. Fox. 2005. Different Helicobacter hepaticus strains with variable genomic content induce various degrees of hepatitis. Infect. Immun.73:8449-8452.
  • 66. Brown, L. M., T. L. Thomas, J. L. Ma, Y. S. Chang, W. C. You, W. D. Liu, L. Zhang, and M. H. Gail. 2001. Helicobacter pylori infection in rural China: exposure to domestic animals during childhood and adulthood. Scand. J. Infect. Dis.33:686-691. [[PubMed]
  • 67. Brown, L. M., T. L. Thomas, J. L. Ma, Y. S. Chang, W. C. You, W. D. Liu, L. Zhang, D. Pee, and M. H. Gail. 2002. Helicobacter pylori infection in rural China: demographic, lifestyle and environmental factors. Int. J. Epidemiol.31:638-645. [[PubMed]
  • 68. Bruggraber, S. F., G. French, R. P. Thompson, and J. J. Powell. 2004. Selective and effective bactericidal activity of the cobalt (II) cation against Helicobacter pylori. Helicobacter9:422-428. [[PubMed]
  • 69. Bukholm, G., T. Tannaes, P. Nedenskov, Y. Esbensen, H. J. Grav, T. Hovig, S. Ariansen, and I. Guldvog. 1997. Colony variation of Helicobacter pylori: pathogenic potential is correlated to cell wall lipid composition. Scand. J. Gastroenterol.32:445-454. [[PubMed]
  • 70. Burne, R. A., and Y. M. Chen. 2000. Bacterial ureases in infectious diseases. Microbes Infect.2:533-542. [[PubMed]
  • 71. Bury-Mone, S., S. Skouloubris, C. Dauga, J. M. Thiberge, D. Dailidiene, D. E. Berg, A. Labigne, and H. De Reuse. 2003. Presence of active aliphatic amidases in Helicobacter species able to colonize the stomach. Infect. Immun.71:5613-5622.
  • 72. Bury-Mone, S., S. Skouloubris, A. Labigne, and H. De Reuse. 2001. The Helicobacter pylori UreI protein: role in adaptation to acidity and identification of residues essential for its activity and for acid activation. Mol. Microbiol.42:1021-1034. [[PubMed]
  • 73. Bury-Mone, S., J. M. Thiberge, M. Contreras, A. Maitournam, A. Labigne, and H. De Reuse. 2004. Responsiveness to acidity via metal ion regulators mediates virulence in the gastric pathogen Helicobacter pylori. Mol. Microbiol.53:623-638. [[PubMed]
  • 74. Bytzer, P., and CO'Morain. 2005. Treatment of Helicobacter pylori. Helicobacter10(Suppl. 1):40-46. [[PubMed][Google Scholar]
  • 75. Calam, J. 1999. Helicobacter pylori modulation of gastric acid. Yale J. Biol. Med.72:195-202.
  • 76. Cats, A., E. J. Kuipers, M. A. Bosschaert, R. G. Pot, C. M. Vandenbroucke-Grauls, and J. G. Kusters. 2003. Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects. Aliment. Pharmacol. Ther.17:429-435. [[PubMed]
  • 77. Cattoli, G., A. Bart, P. S. Klaver, R. J. Robijn, H. J. Beumer, R. van Vugt, R. G. Pot, I. van der Gaag, C. M. Vandenbroucke-Grauls, E. J. Kuipers, and J. G. Kusters. 2000. Helicobacter acinonychis eradication leading to the resolution of gastric lesions in tigers. Vet. Rec.147:164-165. [[PubMed]
  • 78. Cattoli, G., R. van Vugt, R. G. Zanoni, V. Sanguinetti, R. Chiocchetti, M. Gualtieri, C. M. Vandenbroucke-Grauls, W. Gaastra, and J. G. Kusters. 1999. Occurrence and characterization of gastric Helicobacter spp. in naturally infected dogs. Vet. Microbiol.70:239-250. [[PubMed]
  • 79. Cellini, L., N. Allocati, D. Angelucci, T. Iezzi, E. Di Campli, L. Marzio, and B. Dainelli. 1994. Coccoid Helicobacter pylori not culturable in vitro reverts in mice. Microbiol. Immunol.38:843-850. [[PubMed]
  • 80. Censini, S., C. Lange, Z. Xiang, J. E. Crabtree, P. Ghiara, M. Borodovsky, R. Rappuoli, and A. Covacci. 1996. Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. USA93:14648-14653.
  • 81. Chamaillard, M., S. E. Girardin, J. Viala, and D. J. Philpott. 2003. Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation. Cell. Microbiol.5:581-592. [[PubMed]
  • 82. Chan, F. K., S. C. Chung, B. Y. Suen, Y. T. Lee, W. K. Leung, V. K. Leung, J. C. Wu, J. Y. Lau, Y. Hui, M. S. Lai, H. L. Chan, and J. J. Sung. 2001. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N. Engl. J. Med.344:967-973. [[PubMed]
  • 83. Chan, F. K., K. F. To, J. C. Wu, M. Y. Yung, W. K. Leung, T. Kwok, Y. Hui, H. L. Chan, C. S. Chan, E. Hui, J. Woo, and J. J. Sung. 2002. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial. Lancet359:9-13. [[PubMed]
  • 84. Chanto, G., A. Occhialini, N. Gras, R. A. Alm, F. Megraud, and A. Marais. 2002. Identification of strain-specific genes located outside the plasticity zone in nine clinical isolates of Helicobacter pylori. Microbiology148:3671-3680. [[PubMed]
  • 85. Chen, M., A. Lee, and S. L. Hazell. 1992. Immunisation against Helicobacter infection in a mouse/Helicobacter felis model. Lancet339:1120-1121. [[PubMed]
  • 86. Chen, S. Y., T. Y. Liu, C. T. Shun, M. S. Wu, T. H. Lu, J. T. Lin, J. C. Sheu, R. M. Santella, and C. J. Chen. 2004. Modification effects of GSTM1, GSTT1 and CYP2E1 polymorphisms on associations between raw salted food and incomplete intestinal metaplasia in a high-risk area of stomach cancer. Int. J. Cancer108:606-612. [[PubMed]
  • 87. Chen, W., D. Shu, and V. S. Chadwick. 2001. Helicobacter pylori infection: mechanism of colonization and functional dyspepsia. Reduced colonization of gastric mucosa by Helicobacter pylori in mice deficient in interleukin-10. J. Gastroenterol. Hepatol.16:377-383. [[PubMed]
  • 88. Chiba, N., S. J. Van Zanten, P. Sinclair, R. A. Ferguson, S. Escobedo, and E. Grace. 2002. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial. BMJ324:1012-1016.
  • 89. Chiba, N., S. J. Veldhuyzen Van Zanten, S. Escobedo, E. Grace, J. Lee, P. Sinclair, A. Barkun, D. Armstrong, and A. B. Thomson. 2004. Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia. Aliment. Pharmacol. Ther.19:349-358. [[PubMed]
  • 90. Ching, C. K., B. C. Wong, E. Kwok, L. Ong, A. Covacci, and S. K. Lam. 1996. Prevalence of CagA-bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls. Am. J. Gastroenterol.91:949-953. [[PubMed]
  • 91. Christensen, J. M., J. Kristiansen, N. H. Nielsen, T. Menne, and K. Byrialsen. 1999. Nickel concentrations in serum and urine of patients with nickel eczema. Toxicol. Lett.108:185-189. [[PubMed]
  • 92. Christie, P. J., and J. P. Vogel. 2000. Bacterial type IV secretion: conjugation systems adapted to deliver effector molecules to host cells. Trends Microbiol.8:354-360.
  • 93. Coconnier, M. H., V. Lievin, E. Hemery, and A. L. Servin. 1998. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl. Environ. Microbiol.64:4573-4580.
  • 94. Comtois, S. L., M. D. Gidley, and D. J. Kelly. 2003. Role of the thioredoxin system and the thiol-peroxidases Tpx and Bcp in mediating resistance to oxidative and nitrosative stress in Helicobacter pylori. Microbiology149:121-129. [[PubMed]
  • 95. Contreras, M., J. M. Thiberge, M. A. Mandrand-Berthelot, and A. Labigne. 2003. Characterization of the roles of NikR, a nickel-responsive pleiotropic autoregulator of Helicobacter pylori. Mol. Microbiol.49:947-963. [[PubMed]
  • 96. Correa, P., W. Haenszel, C. Cuello, S. Tannenbaum, and M. Archer. 1975. A model for gastric cancer epidemiology. Lancetii:58-59. [[PubMed]
  • 97. Corthesy-Theulaz, I., N. Porta, E. Pringault, L. Racine, A. Bogdanova, J. P. Kraehenbuhl, A. L. Blum, and P. Michetti. 1996. Adhesion of Helicobacter pylori to polarized T84 human intestinal cell monolayers is pH dependent. Infect. Immun.64:3827-3832.
  • 98. Court, M., P. A. Robinson, M. F. Dixon, and J. E. Crabtree. 2002. Gastric Helicobacter species infection in murine and gerbil models: comparative analysis of effects of H. pylori and H. felis on gastric epithelial cell proliferation. J. Infect. Dis.186:1348-1352. [[PubMed]
  • 99. Covacci, A., S. Censini, M. Bugnoli, R. Petracca, D. Burroni, G. Macchia, A. Massone, E. Papini, Z. Xiang, N. Figura, and R. Rappuoli. 1993. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl. Acad. Sci. USA90:5791-5795.
  • 100. Cover, TL. 1996. The vacuolating cytotoxin of Helicobacter pylori. Mol. Microbiol.20:241-246. [[PubMed][Google Scholar]
  • 101. Cover, T. L., and S. R. Blanke. 2005. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat. Rev. Microbiol.3:320-332. [[PubMed]
  • 102. Cover, T. L., and M. J. Blaser. 1992. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J. Biol. Chem.267:10570-10575. [[PubMed]
  • 103. Cover, T. L., Y. Glupczynski, A. P. Lage, A. Burette, M. K. Tummuru, G. I. Perez-Perez, and M. J. Blaser. 1995. Serologic detection of infection with cagAHelicobacter pylori strains. J. Clin. Microbiol.33:1496-1500.
  • 104. Cover, T. L., P. I. Hanson, and J. E. Heuser. 1997. Acid-induced dissociation of VacA, the Helicobacter pylori vacuolating cytotoxin, reveals its pattern of assembly. J. Cell Biol.138:759-769.
  • 105. Cover, T. L., U. S. Krishna, D. A. Israel, and R. M. Peek, Jr. 2003. Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. Cancer Res.63:951-957. [[PubMed]
  • 106. Crabtree, JE. 1998. Eradication of chronic Helicobacter pylori infection by therapeutic vaccination. Gut43:7-8. [Google Scholar]
  • 107. Crabtree, J. E., R. L. Ferrero, and J. G. Kusters. 2002. The mouse colonizing Helicobacter pylori strain SS1 may lack a functional cag pathogenicity island. Helicobacter7:139-151. [[PubMed]
  • 108. Reference deleted.
  • 109. Cussac, V., R. L. Ferrero, and A. Labigne. 1992. Expression of Helicobacter pylori urease genes in Escherichia coli grown under nitrogen-limiting conditions. J. Bacteriol.174:2466-2473.
  • 110. Czinn, S. J., A. Cai, and J. G. Nedrud. 1993. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine11:637-642. [[PubMed]
  • 111. Dailidiene, D., G. Dailide, K. Ogura, M. Zhang, A. K. Mukhopadhyay, K. A. Eaton, G. Cattoli, J. G. Kusters, and D. E. Berg. 2004. Helicobacter acinonychis: genetic and rodent infection studies of a Helicobacter pylori-like gastric pathogen of cheetahs and other big cats. J. Bacteriol.186:356-365.
  • 112. Davis, G. S., and H. L. Mobley. 2005. Contribution of dppA to urease activity in Helicobacter pylori 26695. Helicobacter10:416-423. [[PubMed]
  • 113. de Bernard, M., B. Arico, E. Papini, R. Rizzuto, G. Grandi, R. Rappuoli, and C. Montecucco. 1997. Helicobacter pylori toxin VacA induces vacuole formation by acting in the cell cytosol. Mol. Microbiol.26:665-674. [[PubMed]
  • 114. de Jonge, R., Z. Durrani, S. G. Rijpkema, E. J. Kuipers, A. H. van Vliet, and J. G. Kusters. 2004. Role of the Helicobacter pylori outer-membrane proteins AlpA and AlpB in colonization of the guinea pig stomach. J. Med. Microbiol.53:375-379. [[PubMed]
  • 115. de Jonge, R., E. J. Kuipers, S. C. Langeveld, R. J. Loffeld, J. Stoof, A. H. van Vliet, and J. G. Kusters. 2004. The Helicobacter pylori plasticity region locus jhp0947-jhp0949 is associated with duodenal ulcer disease and interleukin-12 production in monocyte cells. FEMS Immunol. Med. Microbiol.41:161-167. [[PubMed]
  • 116. de Jonge, R., J. G. Kusters, M. S. Timmer, V. Gimmel, B. J. Appelmelk, S. Bereswill, A. H. M. van Vliet, S. G. Meuwissen, M. Kist, C. M. Vandenbroucke-Grauls, and E. J. Kuipers. 2001. The role of Helicobacter pylori virulence factors in interleukin production by monocytic cells. FEMS Microbiol. Lett.196:235-238. [[PubMed]
  • 117. de Jonge, R., R. G. Pot, R. J. Loffeld, A. H. van Vliet, E. J. Kuipers, and J. G. Kusters. 2004. The functional status of the Helicobacter pylori sabB adhesin gene as a putative marker for disease outcome. Helicobacter9:158-164. [[PubMed]
  • 118. Delaney, B., A. Ford, D. Forman, P. Moayyedi, and M. Qume. 2005. Initial management strategies for dyspepsia. Cochrane Database Syst. Rev.2005:CD001961. [[PubMed]
  • 119. D'Elios, M. M., M. Manghetti, M. De Carli, F. Costa, C. T. Baldari, D. Burroni, J. L. Telford, S. Romagnani, and G. Del Prete. 1997. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol.158:962-967. [[PubMed]
  • 120. de Mascarel, A., A. Ruskone-Fourmestraux, A. Lavergne-Slove, F. Megraud, P. Dubus, and J. P. Merlio. 2005. Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue. Virchows Arch.446:219-224. [[PubMed]
  • 121. Dent, J. C., and C. A. McNulty. 1988. Evaluation of a new selective medium for Campylobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis.7:555-558. [[PubMed]
  • 122. de Vries, N., A. H. M. van Vliet, and J. G. Kusters. 2001. Gene regulation, p. 321-334. In H. L. T. Mobley, G. L. Mendz, and S. L. Hazell (ed.), Helicobacter pylori: physiology and genetics. ASM Press, Washington, D.C.
  • 123. Ding, S. Z., A. M. Torok, M. F. Smith, Jr., and J. B. Goldberg. 2005. Toll-like receptor 2-mediated gene expression in epithelial cells during Helicobacter pylori infection. Helicobacter10:193-204. [[PubMed]
  • 124. Doidge, C., I. Gust, A. Lee, F. Buck, S. Hazell, and U. Manne. 1994. Therapeutic immunisation against helicobacter infection. Lancet343:914-915. [[PubMed]
  • 125. Doig, P., J. W. Austin, and T. J. Trust. 1993. The Helicobacter pylori 19.6-kilodalton protein is an iron-containing protein resembling ferritin. J. Bacteriol.175:557-560.
  • 126. Doig, P., B. L. de Jonge, R. A. Alm, E. D. Brown, M. Uria-Nickelsen, B. Noonan, S. D. Mills, P. Tummino, G. Carmel, B. C. Guild, D. T. Moir, G. F. Vovis, and T. J. Trust. 1999. Helicobacter pylori physiology predicted from genomic comparison of two strains. Microbiol. Mol. Biol. Rev.63:675-707.
  • 127. Doig, P., M. M. Exner, R. E. Hancock, and T. J. Trust. 1995. Isolation and characterization of a conserved porin protein from Helicobacter pylori. J. Bacteriol.177:5447-5452.
  • 128. Doig, P., and T. J. Trust. 1994. Identification of surface-exposed outer membrane antigens of Helicobacter pylori. Infect. Immun.62:4526-4533.
  • 129. Donahue, J. P., R. M. Peek, L. J. Van Doorn, S. A. Thompson, Q. Xu, M. J. Blaser, and G. G. Miller. 2000. Analysis of iceA1 transcription in Helicobacter pylori. Helicobacter5:1-12.
  • 130. Dore, M. P., A. R. Sepulveda, H. El-Zimaity, Y. Yamaoka, M. S. Osato, K. Mototsugu, A. M. Nieddu, G. Realdi, and D. Y. Graham. 2001. Isolation of Helicobacter pylori from sheep—implications for transmission to humans. Am. J. Gastroenterol.96:1396-1401. [[PubMed]
  • 131. Dresner, D., W. Coyle, R. Nemec, R. Peterson, T. Duntemann, and J. M. Lawson. 1996. Efficacy of ciprofloxacin in the eradication of Helicobacter pylori. South. Med. J.89:775-778. [[PubMed]
  • 132. Du, Y., A. Agnew, X. P. Ye, P. A. Robinson, D. Forman, and J. E. Crabtree. 2005. Helicobacter pylori and Schistosoma japonicum co-infection in a Chinese population: helminth infection alters humoral responses to H. pylori and serum pepsinogen I/II ratio. Microbes Infect.8:52-60. [[PubMed]
  • 133. Dubois, A., D. E. Berg, N. Fiala, L. M. Heman-Ackah, G. I. Perez-Perez, and M. J. Blaser. 1998. Cure of Helicobacter pylori infection by omeprazole-clarithromycin-based therapy in non-human primates. J. Gastroenterol.33:18-22. [[PubMed]
  • 134. Dubois, A., D. E. Berg, E. T. Incecik, N. Fiala, L. M. Heman-Ackah, G. I. Perez-Perez, and M. J. Blaser. 1996. Transient and persistent experimental infection of nonhuman primates with Helicobacter pylori: implications for human disease. Infect. Immun.64:2885-2891.
  • 135. Dubois, A., N. Fiala, L. M. Heman-Ackah, E. S. Drazek, A. Tarnawski, W. N. Fishbein, G. I. Perez-Perez, and M. J. Blaser. 1994. Natural gastric infection with Helicobacter pylori in monkeys: a model for spiral bacteria infection in humans. Gastroenterology106:1405-1417. [[PubMed]
  • 136. Dubois, A., C. K. Lee, N. Fiala, H. Kleanthous, P. T. Mehlman, and T. Monath. 1998. Immunization against natural Helicobacter pylori infection in nonhuman primates. Infect. Immun.66:4340-4346.
  • 137. Dundon, W. G., A. Polenghi, G. Del Guidice, R. Rappuoli, and C. Montecucco. 2001. Neutrophil-activating protein (HP-NAP) versus ferritin (Pfr): comparison of synthesis in Helicobacter pylori. FEMS Microbiol. Lett.199:143-149. [[PubMed]
  • 138. Dunn, B. E., G. P. Campbell, G. I. Perez-Perez, and M. J. Blaser. 1990. Purification and characterization of urease from Helicobacter pylori. J. Biol. Chem.265:9464-9469. [[PubMed]
  • 139. Dunn, B. E., C. C. Sung, N. S. Taylor, and J. G. Fox. 1991. Purification and characterization of Helicobacter mustelae urease. Infect. Immun.59:3343-3345.
  • 140. Durrani, Z., and SRijpkema. 2003. Orogastric vaccination of guinea pigs with Helicobacter pylori sonicate and a high dose of cholera toxin lowers the burden of infection. FEMS Immunol. Med. Microbiol.36:169-173. [[PubMed][Google Scholar]
  • 141. Eaton, K. A., C. L. Brooks, D. R. Morgan, and S. Krakowka. 1991. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect. Immun.59:2470-2475.
  • 142. Eaton, K. A., C. E. Catrenich, K. M. Makin, and S. Krakowka. 1995. Virulence of coccoid and bacillary forms of Helicobacter pylori in gnotobiotic piglets. J. Infect. Dis.171:459-462. [[PubMed]
  • 143. Eaton, K. A., T. L. Cover, M. K. Tummuru, M. J. Blaser, and S. Krakowka. 1997. Role of vacuolating cytotoxin in gastritis due to Helicobacter pylori in gnotobiotic piglets. Infect. Immun.65:3462-3464.
  • 144. Eaton, K. A., F. E. Dewhirst, B. J. Paster, N. Tzellas, B. E. Coleman, J. Paola, and R. Sherding. 1996. Prevalence and varieties of Helicobacter species in dogs from random sources and pet dogs: animal and public health implications. J. Clin. Microbiol.34:3165-3170.
  • 145. Eaton, K. A., F. E. Dewhirst, M. J. Radin, J. G. Fox, B. J. Paster, S. Krakowka, and D. R. Morgan. 1993. Helicobacter acinonyx sp. nov., isolated from cheetahs with gastritis. Int. J. Syst. Bacteriol.43:99-106. [[PubMed]
  • 146. Eaton, K. A., and S. Krakowka. 1992. Chronic active gastritis due to Helicobacter pylori in immunized gnotobiotic piglets. Gastroenterology103:1580-1586. [[PubMed]
  • 147. Eaton, K. A., and S. Krakowka. 1994. Effect of gastric pH on urease-dependent colonization of gnotobiotic piglets by Helicobacter pylori. Infect. Immun.62:3604-3607.
  • 148. Eaton, K. A., M. Mefford, and T. Thevenot. 2001. The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J. Immunol.166:7456-7461. [[PubMed]
  • 149. Eaton, K. A., and M. E. Mefford. 2001. Cure of Helicobacter pylori infection and resolution of gastritis by adoptive transfer of splenocytes in mice. Infect. Immun.69:1025-1031.
  • 150. Eaton, K. A., D. R. Morgan, and S. Krakowka. 1992. Motility as a factor in the colonisation of gnotobiotic piglets by Helicobacter pylori. J. Med. Microbiol.37:123-127. [[PubMed]
  • 151. Eaton, K. A., S. S. Ringler, and S. Krakowka. 1998. Vaccination of gnotobiotic piglets against Helicobacter pylori. J. Infect. Dis.178:1399-1405. [[PubMed]
  • 152. Ebrahimi-Dariani, N., S. Mirmomen, F. Mansour-Ghanaei, P. Noormohammadpoor, R. Sotodehmanesh, B. Haghpanah, and H. Bahrami. 2003. The efficacy of furazolidone-based quadruple therapy for eradication of Helicobacter pylori infection in Iranian patients resistant to metronidazole-based quadruple therapy. Med. Sci. Monit.9:PI105-PI108. [[PubMed]
  • 153. Edwards, N. J., M. A. Monteiro, G. Faller, E. J. Walsh, A. P. Moran, I. S. Roberts, and N. J. High. 2000. Lewis X structures in the O antigen side-chain promote adhesion of Helicobacter pylori to the gastric epithelium. Mol. Microbiol.35:1530-1539. [[PubMed]
  • 154. Eidt, S., M. Stolte, and R. Fischer. 1994. Helicobacter pylori gastritis and primary gastric non-Hodgkin's lymphomas. J. Clin. Pathol.47:436-439.
  • 155. Ekstrom, A. M., M. Held, L. E. Hansson, L. Engstrand, and O. Nyren. 2001. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology121:784-791. [[PubMed]
  • 156. El-Omar, EM. 2001. The importance of interleukin 1beta in Helicobacter pylori associated disease. Gut48:743-747. [Google Scholar]
  • 157. El-Omar, E. M., M. Carrington, W. H. Chow, K. E. McColl, J. H. Bream, H. A. Young, J. Herrera, J. Lissowska, C. C. Yuan, N. Rothman, G. Lanyon, M. Martin, J. F. Fraumeni, Jr., and C. S. Rabkin. 2000. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature404:398-402. [[PubMed]
  • 158. El-Omar, E. M., K. Oien, A. El-Nujumi, D. Gillen, A. Wirz, S. Dahill, C. Williams, J. E. S. Ardill, and K. E. L. McColl. 1997. Helicobacter pylori infection and chronic acid hyposecretion. Gastroenterology113:15-24. [[PubMed]
  • 159. El-Omar, E. M., C. S. Rabkin, M. D. Gammon, T. L. Vaughan, H. A. Risch, J. B. Schoenberg, J. L. Stanford, S. T. Mayne, J. Goedert, W. J. Blot, J. F. Fraumeni, Jr., and W. H. Chow. 2003. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology124:1193-1201. [[PubMed]
  • 160. Elshal, M. F., I. H. Elsayed, I. M. El Kady, G. Badra, A. El-Refaei, M. El-Batanony, and O. M. Hendy. 2004. Role of concurrent S. mansoni infection in H. pylori-associated gastritis: a flow cytometric DNA-analysis and oxyradicals correlations. Clin. Chim. Acta346:191-198. [[PubMed]
  • 161. Enroth, H., and LEngstrand. 1995. Immunomagnetic separation and PCR for detection of Helicobacter pylori in water and stool specimens. J. Clin. Microbiol.33:2162-2165. [Google Scholar]
  • 162. Enroth, H., K. Wreiber, R. Rigo, D. Risberg, A. Uribe, and L. Engstrand. 1999. In vitro aging of Helicobacter pylori: changes in morphology, intracellular composition and surface properties. Helicobacter4:7-16. [[PubMed]
  • 163. Erdman, S. E., P. Correa, L. A. Coleman, M. D. Schrenzel, X. Li, and J. G. Fox. 1997. Helicobacter mustelae-associated gastric MALT lymphoma in ferrets. Am. J. Pathol.151:273-280.
  • 164. Ermak, T. H., P. J. Giannasca, R. Nichols, G. A. Myers, J. Nedrud, R. Weltzin, C. K. Lee, H. Kleanthous, and T. P. Monath. 1998. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J. Exp. Med.188:2277-2288.
  • 165. Ernst, F. D., S. Bereswill, B. Waidner, J. Stoof, U. Mader, J. G. Kusters, E. J. Kuipers, M. Kist, A. H. van Vliet, and G. Homuth. 2005. Transcriptional profiling of Helicobacter pylori Fur- and iron-regulated gene expression. Microbiology151:533-546. [[PubMed]
  • 166. Ernst, F. D., G. Homuth, J. Stoof, U. Mäder, B. Waidner, E. J. Kuipers, M. Kist, J. G. Kusters, S. Bereswill, and A. H. M. van Vliet. 2005. Iron-responsive regulation of the Helicobacter pylori iron-cofactored superoxide dismutase SodB is mediated by Fur. J. Bacteriol.187:3687-3692.
  • 167. Ernst, F. D., E. J. Kuipers, A. Heijens, R. Sarwari, J. Stoof, C. W. Penn, J. G. Kusters, and A. H. van Vliet. 2005. The nickel-responsive regulator NikR controls activation and repression of gene transcription in Helicobacter pylori. Infect. Immun.73:7252-7258.
  • 168. Ernst, P. B., and B. D. Gold. 2000. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu. Rev. Microbiol.54:615-640. [[PubMed]
  • 169. Euler, A. R., G. E. Zurenko, J. B. Moe, R. G. Ulrich, and Y. Yagi. 1990. Evaluation of two monkey species (Macaca mulatta and Macaca fascicularis) as possible models for human Helicobacter pylori disease. J. Clin. Microbiol.28:2285-2290.
  • 170. Evans, D. G., and D. J. Evans, Jr. 1995. Adhesion properties of Helicobacter pylori. Methods Enzymol.253:336-360. [[PubMed]
  • 171. Evans, D. J., Jr., and D. G. Evans. 2000. Helicobacter pylori adhesins: review and perspectives. Helicobacter5:183-195. [[PubMed]
  • 172. Evans, D. J., Jr., D. G. Evans, T. Takemura, H. Nakano, H. C. Lampert, D. Y. Graham, D. N. Granger, and P. R. Kvietys. 1995. Characterization of a Helicobacter pylori neutrophil-activating protein. Infect. Immun.63:2213-2220.
  • 173. Fakheri, H., S. Merat, V. Hosseini, and R. Malekzadeh. 2004. Low-dose furazolidone in triple and quadruple regimens for Helicobacter pylori eradication. Aliment. Pharmacol. Ther.19:89-93. [[PubMed]
  • 174. Fallone, C. A., A. N. Barkun, M. U. Gottke, L. M. Best, V. G. Loo, S. Veldhuyzen van Zanten, T. Nguyen, A. Lowe, T. Fainsilber, K. Kouri, and R. Beech. 2000. Association of Helicobacter pylori genotype with gastroesophageal reflux disease and other upper gastrointestinal diseases. Am. J. Gastroenterol.95:659-669. [[PubMed]
  • 175. Falush, D., C. Kraft, N. S. Taylor, P. Correa, J. G. Fox, M. Achtman, and S. Suerbaum. 2001. Recombination and mutation during long-term gastric colonization by Helicobacter pylori: estimates of clock rates, recombination size, and minimal age. Proc. Natl. Acad. Sci. USA98:15056-15061.
  • 176. Falush, D., T. Wirth, B. Linz, J. K. Pritchard, M. Stephens, M. Kidd, M. J. Blaser, D. Y. Graham, S. Vacher, G. I. Perez-Perez, Y. Yamaoka, F. Megraud, K. Otto, U. Reichard, E. Katzowitsch, X. Wang, M. Achtman, and S. Suerbaum. 2003. Traces of human migrations in Helicobacter pylori populations. Science299:1582-1585. [[PubMed]
  • 177. Ferguson, D. A., Jr., C. Jiang, D. S. Chi, J. J. Laffan, C. Li, and E. Thomas. 1999. Evaluation of two string tests for obtaining gastric juice for culture, nested-PCR detection, and combined single- and double-stranded conformational polymorphism discrimination of Helicobacter pylori. Dig. Dis. Sci.44:2056-2062. [[PubMed]
  • 178. Ferguson, D. A., Jr., C. Li, N. R. Patel, W. R. Mayberry, D. S. Chi, and E. Thomas. 1993. Isolation of Helicobacter pylori from saliva. J. Clin. Microbiol.31:2802-2804.
  • 179. Ferrero, RL. 2005. Innate immune recognition of the extracellular mucosal pathogen, Helicobacter pylori. Mol. Immunol.42:879-885. [[PubMed][Google Scholar]
  • 180. Ferrero, R. L., P. Ave, F. J. Radcliff, A. Labigne, and M. R. Huerre. 2000. Outbred mice with long-term Helicobacter felis infection develop both gastric lymphoid tissue and glandular hyperplastic lesions. J. Pathol.191:333-340. [[PubMed]
  • 181. Ferrero, R. L., and A. Labigne. 1993. Cloning, expression and sequencing of Helicobacter felis urease genes. Mol. Microbiol.9:323-333. [[PubMed]
  • 182. Ferrero, R. L., and A. Lee. 1991. The importance of urease in acid protection for the gastric-colonising bacteria Helicobacter pylori and Helicobacter felis sp. nov. Microbiol. Ecol. Health Dis.4:121-134. [PubMed]
  • 183. Ferrero, R. L., J. M. Thiberge, I. Kansau, N. Wuscher, M. Huerre, and A. Labigne. 1995. The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc. Natl. Acad. Sci. USA92:6499-6503.
  • 184. Fiedorek, S. C., H. M. Malaty, D. L. Evans, C. L. Pumphrey, H. B. Casteel, D. J. Evans, Jr., and D. Y. Graham. 1991. Factors influencing the epidemiology of Helicobacter pylori infection in children. Pediatrics88:578-582. [[PubMed]
  • 185. Figueiredo, C., W. G. Quint, R. Sanna, E. Sablon, J. P. Donahue, Q. Xu, G. G. Miller, R. M. Peek, Jr., M. J. Blaser, and L. J. van Doorn. 2000. Genetic organization and heterogeneity of the iceA locus of Helicobacter pylori. Gene246:59-68. [[PubMed]
  • 186. Fischbach, W., M. E. Goebeler-Kolve, B. Dragosics, A. Greiner, and M. Stolte. 2004. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut53:34-37.
  • 187. Fischer, W., J. Puls, R. Buhrdorf, B. Gebert, S. Odenbreit, and R. Haas. 2001. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol. Microbiol.42:1337-1348. [[PubMed]
  • 188. Fitchen, N., D. P. Letley, P. O'Shea, J. C. Atherton, P. Williams, and K. R. Hardie. 2005. All subtypes of the cytotoxin VacA adsorb to the surface of Helicobacter pylori post-secretion. J. Med. Microbiol.54:621-630. [[PubMed]
  • 189. Foltz, C. J., J. G. Fox, L. Yan, and B. Shames. 1995. Evaluation of antibiotic therapies for eradication of Helicobacter hepaticus. Antimicrob. Agents Chemother.39:1292-1294.
  • 190. Ford, A. C., M. Qume, P. Moayyedi, N. L. Arents, A. T. Lassen, R. F. Logan, K. E. McColl, P. Myres, and B. C. Delaney. 2005. Helicobacter pylori “test and treat” or endoscopy for managing dyspepsia: an individual patient data meta-analysis. Gastroenterology128:1838-1844. [[PubMed]
  • 191. Forman, D., F. Sitas, D. G. Newell, A. R. Stacey, J. Boreham, R. Peto, T. C. Campbell, J. Li, and J. Chen. 1990. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int. J. Cancer46:608-611. [[PubMed]
  • 192. Forsmark, C. E., C. M. Wilcox, J. P. Cello, W. Margaretten, B. Lee, M. Sachdeeva, J. Satow, and M. A. Sande. 1990. Ciprofloxacin in the treatment of Helicobacter pylori in patients with gastritis and peptic ulcer. J. Infect. Dis.162:998-999. [[PubMed]
  • 193. Fox, JG. 1998. Anatomy of the ferret, p. 19-69. In J. G. Fox (ed.), Biology and diseases of the ferret. The Williams &amp; Wilkins Co., Baltimore, Md.[Google Scholar]
  • 194. Fox, JG. 2002. The non-H. pylori helicobacters: their expanding role in gastrointestinal and systemic diseases. Gut50:273-283. [Google Scholar]
  • 195. Fox, JG. 1995. Nonhuman reservoirs of Helicobacter pylori. Aliment. Pharmacol. Ther.9(Suppl. 2):93-103. [[PubMed][Google Scholar]
  • 196. Fox, J. G., P. Beck, C. A. Dangler, M. T. Whary, T. C. Wang, H. N. Shi, and C. Nagler-Anderson. 2000. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat. Med.6:536-542. [[PubMed]
  • 197. Fox, J. G., E. B. Cabot, N. S. Taylor, and R. Laraway. 1988. Gastric colonization by Campylobacter pylori subsp. mustelae in ferrets. Infect. Immun.56:2994-2996.
  • 198. Fox, J. G., T. Chilvers, C. S. Goodwin, N. S. Taylor, P. Edmonds, L. I. Sly, and D. Brenner. 1989. Campylobacter mustelae, a new species resulting from the elevation of Campylobacter pylori subsp. mustelae to species status. Int. J. Syst. Bacteriol.39:301-303. [PubMed]
  • 199. Fox, J. G., P. Correa, N. S. Taylor, A. Lee, G. Otto, J. C. Murphy, and R. Rose. 1990. Helicobacter mustelae-associated gastritis in ferrets. An animal model of Helicobacter pylori gastritis in humans. Gastroenterology99:352-361. [[PubMed]
  • 200. Fox, J. G., C. A. Dangler, W. Sager, R. Borkowski, and J. M. Gliatto. 1997. Helicobacter mustelae-associated gastric adenocarcinoma in ferrets (Mustela putorius furo). Vet. Pathol.34:225-229. [[PubMed]
  • 201. Fox, J. G., F. E. Dewhirst, J. G. Tully, B. J. Paster, L. Yan, N. S. Taylor, M. J. Collins, Jr., P. L. Gorelick, and J. M. Ward. 1994. Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J. Clin. Microbiol.32:1238-1245.
  • 202. Fox, J. G., B. M. Edrise, E. B. Cabot, C. Beaucage, J. C. Murphy, and K. S. Prostak. 1986. Campylobacter-like organisms isolated from gastric mucosa of ferrets. Am. J. Vet. Res.47:236-239. [[PubMed]
  • 203. Fox, J. G., A. B. Rogers, M. Ihrig, N. S. Taylor, M. T. Whary, G. Dockray, A. Varro, and T. C. Wang. 2003. Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Res.63:942-950. [[PubMed]
  • 204. Franco, A. T., D. A. Israel, M. K. Washington, U. Krishna, J. G. Fox, A. B. Rogers, A. S. Neish, L. Collier-Hyams, G. I. Perez-Perez, M. Hatakeyama, R. Whitehead, K. Gaus, D. P. O'Brien, J. Romero-Gallo, and R. M. Peek, Jr. 2005. Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc. Natl. Acad. Sci. USA102:10646-10651.
  • 205. Frazier, B. A., J. D. Pfeifer, D. G. Russell, P. Falk, A. N. Olsen, M. Hammar, T. U. Westblom, and S. J. Normark. 1993. Paracrystalline inclusions of a novel ferritin containing nonheme iron, produced by the human gastric pathogen Helicobacter pylori: evidence for a third class of ferritins. J. Bacteriol.175:966-972.
  • 206. Fulkerson, J. F., Jr., R. M. Garner, and H. L. Mobley. 1998. Conserved residues and motifs in the NixA protein of Helicobacter pylori are critical for the high affinity transport of nickel ions. J. Biol. Chem.273:235-241. [[PubMed]
  • 207. Furesz, J., S. Lakatos, K. Nemeth, P. Fritz, L. Simon, and K. Kacserka. 2004. The prevalence and incidence of Helicobacter pylori infections among young recruits during service in the Hungarian Army. Helicobacter9:77-80. [[PubMed]
  • 208. Furuta, T., E. M. El-Omar, F. Xiao, N. Shirai, M. Takashima, and H. Sugimura. 2002. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology123:92-105. [[PubMed]
  • 209. Furuta, T., K. Ohashi, K. Kosuge, X. J. Zhao, M. Takashima, M. Kimura, M. Nishimoto, H. Hanai, E. Kaneko, and T. Ishizaki. 1999. CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans. Clin. Pharmacol. Ther.65:552-561. [[PubMed]
  • 210. Furuta, T., N. Shirai, M. Takashima, F. Xiao, H. Hanai, H. Sugimura, K. Ohashi, T. Ishizaki, and E. Kaneko. 2001. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin. Clin. Pharmacol. Ther.69:158-168. [[PubMed]
  • 211. Furuta, T., N. Shirai, F. Xiao, E. M. El-Omar, C. S. Rabkin, H. Sugimura, T. Ishizaki, and K. Ohashi. 2004. Polymorphism of interleukin-1beta affects the eradication rates of Helicobacter pylori by triple therapy. Clin. Gastroenterol. Hepatol.2:22-30. [[PubMed]
  • 212. Galmiche, A., J. Rassow, A. Doye, S. Cagnol, J. C. Chambard, S. Contamin, V. de Thillot, I. Just, V. Ricci, E. Solcia, E. Van Obberghen, and P. Boquet. 2000. The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J.19:6361-6370.
  • 213. Garner, R. M., J. Fulkerson, Jr., and H. L. Mobley. 1998. Helicobacter pylori glutamine synthetase lacks features associated with transcriptional and posttranslational regulation. Infect. Immun.66:1839-1847.
  • 214. Gasbarrini, A., E. Carloni, G. Gasbarrini, and S. A. Chisholm. 2004. Helicobacter pylori and extragastric diseases—other Helicobacters. Helicobacter9(Suppl. 1):57-66. [[PubMed]
  • 215. Gasbarrini, A., and FFranceschi. 2005. Does H. pylori infection play a role in idiopathic thrombocytopenic purpura and in other autoimmune diseases? Am. J. Gastroenterol.100:1271-1273. [[PubMed][Google Scholar]
  • 216. Ge, Z., and D. E. Taylor. 1996. Helicobacter pylori genes hpcopA and hpcopP constitute a cop operon involved in copper export. FEMS Microbiol. Lett.145:181-188. [[PubMed]
  • 217. Gebert, B., W. Fischer, and R. Haas. 2004. The Helicobacter pylori vacuolating cytotoxin: from cellular vacuolation to immunosuppressive activities. Rev. Physiol. Biochem. Pharmacol.152:205-220. [[PubMed]
  • 218. Gebert, B., W. Fischer, E. Weiss, R. Hoffmann, and R. Haas. 2003. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science301:1099-1102. [[PubMed]
  • 219. Geijtenbeek, T. B., D. S. Kwon, R. Torensma, S. J. van Vliet, G. C. van Duijnhoven, J. Middel, I. L. Cornelissen, H. S. Nottet, V. N. KewalRamani, D. R. Littman, C. G. Figdor, and Y. van Kooyk. 2000. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell100:587-597. [[PubMed]
  • 220. Genta, RM. 2002. Review article: after gastritis—an imaginary journey into a Helicobacter-free world. Aliment. Pharmacol. Ther.16(Suppl. 4):89-94. [[PubMed][Google Scholar]
  • 221. Gerhard, M., N. Lehn, N. Neumayer, T. Boren, R. Rad, W. Schepp, S. Miehlke, M. Classen, and C. Prinz. 1999. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc. Natl. Acad. Sci. USA96:12778-12783.
  • 222. Gewirtz, A. T., Y. Yu, U. S. Krishna, D. A. Israel, S. L. Lyons, and R. M. Peek, Jr. 2004. Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity. J. Infect. Dis.189:1914-1920. [[PubMed]
  • 223. Ghiara, P., M. Marchetti, M. J. Blaser, M. K. Tummuru, T. L. Cover, E. D. Segal, L. S. Tompkins, and R. Rappuoli. 1995. Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infect. Immun.63:4154-4160.
  • 224. Ghiara, P., M. Rossi, M. Marchetti, A. Di Tommaso, C. Vindigni, F. Ciampolini, A. Covacci, J. L. Telford, M. T. De Magistris, M. Pizza, R. Rappuoli, and G. Del Giudice. 1997. Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection. Infect. Immun.65:4996-5002.
  • 225. Gilbert, J. V., J. Ramakrishna, F. W. Sunderman, Jr., A. Wright, and A. G. Plaut. 1995. Protein Hpn: cloning and characterization of a histidine-rich metal-binding polypeptide in Helicobacter pylori and Helicobacter mustelae. Infect. Immun.63:2682-2688.
  • 226. Gisbert, J. P., S. Khorrami, F. Carballo, X. Calvet, E. Gene, and E. Dominguez-Munoz. 2004. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. Aliment. Pharmacol. Ther.19:617-629. [[PubMed]
  • 227. Gisbert, J. P., and J. M. Pajares. 2002. Review article: Helicobacter pylori “rescue” regimen when proton pump inhibitor-based triple therapies fail. Aliment. Pharmacol. Ther.16:1047-1057. [[PubMed]
  • 228. Gisbert, J. P., and J. M. Pajares. 2005. Systematic review and meta-analysis: is 1-week proton pump inhibitor-based triple therapy sufficient to heal peptic ulcer? Aliment. Pharmacol. Ther.21:795-804. [[PubMed]
  • 229. Go, M. F., and D. Y. Graham. 1996. Presence of the cagA gene in the majority of Helicobacter pylori strains is independent of whether the individual has duodenal ulcer or asymptomatic gastritis. Helicobacter1:107-111. [[PubMed]
  • 230. Gobert, A. P., J. C. Bambou, C. Werts, V. Balloy, M. Chignard, A. P. Moran, and R. L. Ferrero. 2004. Helicobacter pylori heat shock protein 60 mediates interleukin-6 production by macrophages via a toll-like receptor (TLR)-2-, TLR-4-, and myeloid differentiation factor 88-independent mechanism. J. Biol. Chem.279:245-250. [[PubMed]
  • 231. Gobert, A. P., Y. Cheng, J. Y. Wang, J. L. Boucher, R. K. Iyer, S. D. Cederbaum, R. A. Casero, Jr., J. C. Newton, and K. T. Wilson. 2002. Helicobacter pylori induces macrophage apoptosis by activation of arginase II. J. Immunol.168:4692-4700. [[PubMed]
  • 232. Gobert, A. P., D. J. McGee, M. Akhtar, G. L. Mendz, J. C. Newton, Y. Cheng, H. L. Mobley, and K. T. Wilson. 2001. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc. Natl. Acad. Sci. USA98:13844-13849.
  • 233. Goodman, K. J., and P. Correa. 2000. Transmission of Helicobacter pylori among siblings. Lancet355:358-362. [[PubMed]
  • 234. Goodwin, C. S., J. A. Armstrong, T. Chilvers, M. Peters, M. D. Colins, L. Sly, W. McConnell, and W. E. S. Harper. 1989. Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov. as Helicobacter pylori comb. nov. and Helicobacter mustelae comb. nov., respectively. Int. J. Syst. Bacteriol.39:397-405. [PubMed]
  • 235. Gottwein, J. M., T. G. Blanchard, O. S. Targoni, J. C. Eisenberg, B. M. Zagorski, R. W. Redline, J. G. Nedrud, M. Tary-Lehmann, P. V. Lehmann, and S. J. Czinn. 2001. Protective anti-Helicobacter immunity is induced with aluminum hydroxide or complete Freund's adjuvant by systemic immunization. J. Infect. Dis.184:308-314. [[PubMed]
  • 236. Graham, D. Y., L. C. Alpert, J. L. Smith, and H. H. Yoshimura. 1988. Iatrogenic Campylobacter pylori infection is a cause of epidemic achlorhydria. Am. J. Gastroenterol.83:974-980. [[PubMed]
  • 237. Graham, D. Y., A. R. Opekun, and P. D. Klein. 1993. Clarithromycin for the eradication of Helicobacter pylori. J. Clin. Gastroenterol.16:292-294. [[PubMed]
  • 238. Graham, D. Y., A. R. Opekun, M. S. Osato, H. M. El-Zimaity, C. K. Lee, Y. Yamaoka, W. A. Qureshi, M. Cadoz, and T. P. Monath. 2004. Challenge model for Helicobacter pylori infection in human volunteers. Gut53:1235-1243.
  • 239. Granstrom, M., Y. Tindberg, and M. Blennow. 1997. Seroepidemiology of Helicobacter pylori infection in a cohort of children monitored from 6 months to 11 years of age. J. Clin. Microbiol.35:468-470.
  • 240. Green, W. B., K. Eaton, and S. Krakowka. 1997. Porcine gastric mucosa associated lymphoid tissue (MALT): stimulation by colonization with the gastric bacterial pathogen, Helicobacter pylori. Vet. Immunol. Immunopathol.56:119-131. [[PubMed]
  • 241. Gressmann, H., B. Linz, R. Ghai, K. P. Pleissner, R. Schlapbach, Y. Yamaoka, C. Kraft, S. Suerbaum, T. F. Meyer, and M. Achtman. 2005. Gain and loss of multiple genes during the evolution of Helicobacter pylori. PLoS Genet.1:e43.
  • 242. Gueneau, P., and SLoiseaux-De Goer. 2002. Helicobacter: molecular phylogeny and the origin of gastric colonization in the genus. Infect. Genet. Evol.1:215-223. [[PubMed][Google Scholar]
  • 243. Guiney, D. G., P. Hasegawa, and S. P. Cole. 2003. Helicobacter pylori preferentially induces interleukin 12 (IL-12) rather than IL-6 or IL-10 in human dendritic cells. Infect. Immun.71:4163-4166.
  • 244. Gunn, M. C., J. C. Stephens, J. A. Stewart, B. J. Rathbone, and K. P. West. 1998. The significance of cagA and vacA subtypes of Helicobacter pylori in the pathogenesis of inflammation and peptic ulceration. J. Clin. Pathol.51:761-764.
  • 245. Guo, C. Y., Y. B. Wu, H. L. Liu, J. Y. Wu, and M. Z. Zhong. 2004. Clinical evaluation of four one-week triple therapy regimens in eradicating Helicobacter pylori infection. World J. Gastroenterol.10:747-749.
  • 246. Guruge, J. L., P. G. Falk, R. G. Lorenz, M. Dans, H. P. Wirth, M. J. Blaser, D. E. Berg, and J. I. Gordon. 1998. Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc. Natl. Acad. Sci. USA95:3925-3930.
  • 247. Gyulai, Z., G. Klausz, A. Tiszai, Z. Lenart, I. T. Kasa, J. Lonovics, and Y. Mandi. 2004. Genetic polymorphism of interleukin-8 (IL-8) is associated with Helicobacter pylori-induced duodenal ulcer. Eur. Cytokine Netw.15:353-358. [[PubMed]
  • 248. Ha, N. C., S. T. Oh, J. Y. Sung, K. A. Cha, M. H. Lee, and B. H. Oh. 2001. Supramolecular assembly and acid resistance of Helicobacter pylori urease. Nat. Struct. Biol.8:505-509. [[PubMed]
  • 249. Hafsi, N., P. Voland, S. Schwendy, R. Rad, W. Reindl, M. Gerhard, and C. Prinz. 2004. Human dendritic cells respond to Helicobacter pylori, promoting NK cell and Th1-effector responses in vitro. J. Immunol.173:1249-1257. [[PubMed]
  • 250. Hamajima, N., N. Katsuda, K. Matsuo, T. Saito, K. Hirose, M. Inoue, T. T. Zaki, K. Tajima, and S. Tominaga. 2003. High anti-Helicobacter pylori antibody seropositivity associated with the combination of IL-8-251TT and IL-10-819TT genotypes. Helicobacter8:105-110. [[PubMed]
  • 251. Hamajima, N., K. Matsuo, T. Suzuki, T. Nakamura, A. Matsuura, K. Tajima, and S. Tominaga. 2001. Low expression myeloperoxidase genotype negatively associated with Helicobacter pylori infection. Jpn. J. Cancer Res.92:488-493.
  • 252. Hamajima, N., A. Shibata, N. Katsuda, K. Matsuo, H. Ito, T. Saito, K. Tajima, and S. Tominaga. 2003. Subjects with TNF-A-857TT and -1031TT genotypes showed the highest Helicobacter pylori seropositive rate compared with those with other genotypes. Gastric Cancer6:230-236. [[PubMed]
  • 253. Hamlet, A., A. C. Thoreson, O. Nilsson, A. M. Svennerholm, and L. Olbe. 1999. Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers. Gastroenterology116:259-268. [[PubMed]
  • 254. Han, S. W., R. Flamm, C. Y. Hachem, H. Y. Kim, J. E. Clarridge, D. G. Evans, J. Beyer, J. Drnec, and D. Y. Graham. 1995. Transport and storage of Helicobacter pylori from gastric mucosal biopsies and clinical isolates. Eur. J. Clin. Microbiol. Infect. Dis.14:349-352. [[PubMed]
  • 255. Hansson, L. E., O. Nyrén, A. W. Hsing, R. Bergström, S. Josefsson, W. H. Chow, J. F. Fraumeni, and H. O. Adami. 1996. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N. Engl. J. Med.335:242-249. [[PubMed]
  • 256. Haque, M., Y. Hirai, K. Yokota, N. Mori, I. Jahan, H. Ito, H. Hotta, I. Yano, Y. Kanemasa, and K. Oguma. 1996. Lipid profile of Helicobacter spp.: presence of cholesteryl glucoside as a characteristic feature. J. Bacteriol.178:2065-2070.
  • 257. Harris, A. G., F. E. Hinds, A. G. Beckhouse, T. Kolesnikow, and S. L. Hazell. 2002. Resistance to hydrogen peroxide in Helicobacter pylori: role of catalase (KatA) and Fur, and functional analysis of a novel gene product designated ‘KatA-associated protein,’ KapA (HP0874). Microbiology148:3813-3825. [[PubMed]
  • 258. Harris, A. G., J. E. Wilson, S. J. Danon, M. F. Dixon, K. Donegan, and S. L. Hazell. 2003. Catalase (KatA) and KatA-associated protein (KapA) are essential to persistent colonization in the Helicobacter pylori SS1 mouse model. Microbiology149:665-672. [[PubMed]
  • 259. Harris, P. R., L. E. Smythies, P. D. Smith, and A. Dubois. 2000. Inflammatory cytokine mRNA expression during early and persistent Helicobacter pylori infection in nonhuman primates. J. Infect. Dis.181:783-786. [[PubMed]
  • 260. Hatakeyama, M. 2004. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat. Rev. Cancer4:688-694. [[PubMed]
  • 261. Hawkey, C. J., Z. Tulassay, L. Szczepanski, C. J. van Rensburg, A. Filipowicz-Sosnowska, A. Lanas, C. M. Wason, R. A. Peacock, and K. R. Gillon. 1998. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Lancet352:1016-1021. [[PubMed]
  • 262. Hegarty, J. P., M. T. Dowd, and K. H. Baker. 1999. Occurrence of Helicobacter pylori in surface water in the United States. J. Appl. Microbiol.87:697-701. [[PubMed]
  • 263. Hellmig, S., W. Fischbach, M. E. Goebeler-Kolve, U. R. Folsch, J. Hampe, and S. Schreiber. 2005. Association study of a functional Toll-like receptor 4 polymorphism with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. Leuk. Lymphoma46:869-872. [[PubMed]
  • 264. Hellmig, S., J. Hampe, U. R. Folsch, and S. Schreiber. 2005. Role of IL-10 promoter haplotypes in Helicobacter pylori associated gastric inflammation. Gut54:888.
  • 265. Hellmig, S., J. Hampe, and S. Schreiber. 2003. Helicobacter pylori infection in Africa and Europe: enigma of host genetics. Gut52:1799.
  • 266. Hendricks, J. K., and H. L. Mobley. 1997. Helicobacter pylori ABC transporter: effect of allelic exchange mutagenesis on urease activity. J. Bacteriol.179:5892-5902.
  • 267. Hennig, E. E., M. M. Godlewski, E. Butruk, and J. Ostrowski. 2005. Helicobacter pylori VacA cytotoxin interacts with fibronectin and alters HeLa cell adhesion and cytoskeletal organization in vitro. FEMS Immunol. Med. Microbiol.44:143-150. [[PubMed]
  • 268. Hentschell, E., G. Brandstätter, B. Dragosics, A. M. Hirschl, H. Nemec, K. Schütze, M. Taufer, and H. Wurzer. 1993. Effect of ranitidine and amoxycillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N. Engl. J. Med.328:308-312. [[PubMed]
  • 269. Herbarth, O., P. Krumbiegel, G. J. Fritz, M. Richter, U. Schlink, D. M. Muller, and T. Richter. 2001. Helicobacter pylori prevalences and risk factors among school beginners in a German urban center and its rural county. Environ. Health Perspect.109:573-577.
  • 270. Heuermann, D., and RHaas. 1995. Genetic organization of a small cryptic plasmid of Helicobacter pylori. Gene165:17-24. [[PubMed][Google Scholar]
  • 271. Heuermann, D., and RHaas. 1998. A stable shuttle vector system for efficient genetic complementation of Helicobacter pylori strains by transformation and conjugation. Mol. Gen. Genet.257:519-528. [[PubMed][Google Scholar]
  • 272. Higashi, H., R. Tsutsumi, A. Fujita, S. Yamazaki, M. Asaka, T. Azuma, and M. Hatakeyama. 2002. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc. Natl. Acad. Sci. USA99:14428-14433.
  • 273. Higashi, H., R. Tsutsumi, S. Muto, T. Sugiyama, T. Azuma, M. Asaka, and M. Hatakeyama. 2002. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science295:683-686. [[PubMed]
  • 274. Hirayama, F., S. Takagi, H. Kusuhara, E. Iwao, Y. Yokoyama, and Y. Ikeda. 1996. Induction of gastric ulcer and intestinal metaplasia in Mongolian gerbils infected with Helicobacter pylori. J. Gastroenterol.31:755-757. [[PubMed]
  • 275. Holtmann, G., C. Cain, and P. Malfertheiner. 1999. Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. Gastroenterology117:11-16. [[PubMed]
  • 276. Honda, S., T. Fujioka, M. Tokieda, T. Gotoh, A. Nishizono, and M. Nasu. 1998. Gastric ulcer, atrophic gastritis, and intestinal metaplasia caused by Helicobacter pylori infection in Mongolian gerbils. Scand. J. Gastroenterol.33:454-460. [[PubMed]
  • 277. Honda, S., T. Fujioka, M. Tokieda, R. Satoh, A. Nishizono, and M. Nasu. 1998. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res.58:4255-4259. [[PubMed]
  • 278. Hone, D., and JHackett. 1989. Vaccination against enteric bacterial diseases. Rev. Infect. Dis.11:853-877. [[PubMed][Google Scholar]
  • 279. Hornef, M. W., and C. Bogdan. 2005. The role of epithelial Toll-like receptor expression in host defense and microbial tolerance. J. Endotoxin Res.11:124-128. [[PubMed]
  • 280. Huang, J. Q., S. Sridhar, and R. H. Hunt. 2002. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet359:14-22. [[PubMed]
  • 281. Huesca, M., A. Goodwin, A. Bhagwansingh, P. Hoffman, and C. A. Lingwood. 1998. Characterization of an acidic-pH-inducible stress protein (Hsp70), a putative sulfatide binding adhesin, from Helicobacter pylori. Infect. Immun.66:4061-4067.
  • 282. Hung, L. C., J. Y. Ching, J. J. Sung, K. F. To, A. J. Hui, V. W. Wong, R. W. Leong, H. L. Chan, J. C. Wu, W. K. Leung, Y. T. Lee, S. C. Chung, and F. K. Chan. 2005. Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a prospective cohort study. Gastroenterology128:1845-1850. [[PubMed]
  • 283. Hwang, I. R., T. Kodama, S. Kikuchi, K. Sakai, L. E. Peterson, D. Y. Graham, and Y. Yamaoka. 2002. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology123:1793-1803. [[PubMed]
  • 284. Ikehara, Y., S. Nishihara, H. Yasutomi, T. Kitamura, K. Matsuo, N. Shimizu, K. Inada, Y. Kodera, Y. Yamamura, H. Narimatsu, N. Hamajima, and M. Tatematsu. 2001. Polymorphisms of two fucosyltransferase genes (Lewis and Secretor genes) involving type I Lewis antigens are associated with the presence of anti-Helicobacter pylori IgG antibody. Cancer Epidemiol. Biomarkers Prev.10:971-977. [[PubMed]
  • 285. Ilver, D., A. Arnqvist, J. Ogren, I. M. Frick, D. Kersulyte, E. T. Incecik, D. E. Berg, A. Covacci, L. Engstrand, and T. Boren. 1998. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science279:373-377. [[PubMed]
  • 286. Ilver, D., S. Barone, D. Mercati, P. Lupetti, and J. L. Telford. 2004. Helicobacter pylori toxin VacA is transferred to host cells via a novel contact-dependent mechanism. Cell. Microbiol.6:167-174. [[PubMed]
  • 287. Inagaki, H., T. Nakamura, C. Li, T. Sugiyama, M. Asaka, J. Kodaira, M. Iwano, T. Chiba, K. Okazaki, A. Kato, R. Ueda, T. Eimoto, S. Okamoto, N. Sasaki, N. Uemura, T. Akamatsu, H. Miyabayashi, Y. Kawamura, H. Goto, Y. Niwa, T. Yokoi, M. Seto, and S. Nakamura. 2004. Gastric MALT lymphomas are divided into three groups based on responsiveness to Helicobacter pylori eradication and detection of API2-MALT1 fusion. Am. J. Surg. Pathol.28:1560-1567. [[PubMed]
  • 288. Inohara, N., Y. Ogura, F. F. Chen, A. Muto, and G. Nunez. 2001. Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J. Biol. Chem.276:2551-2554. [[PubMed]
  • 289. International Agency for Research on Cancer. 1994. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 61: schistosomes, liver flukes and Helicobacter pylori. International Agency for Research on Cancer, Lyon, France.
  • 290. Ismail, H. F., P. Fick, J. Zhang, R. G. Lynch, and D. J. Berg. 2003. Depletion of neutrophils in IL-10(−/−) mice delays clearance of gastric Helicobacter infection and decreases the Th1 immune response to Helicobacter. J. Immunol.170:3782-3789. [[PubMed]
  • 291. Jackson, S., P. L. Beck, G. F. Pineo, and M. C. Poon. 2005. Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura? A review of the literature. Am. J. Hematol.78:142-150. [[PubMed]
  • 292. Jeremy, A. H., Y. Du, M. F. Dixon, P. A. Robinson, and J. E. Crabtree. 2005. Protection against Helicobacter pylori infection in the Mongolian gerbil after prophylactic vaccination. Microbes Infect.8:340-346. [[PubMed]
  • 293. Ji, X., T. Fernandez, D. Burroni, C. Pagliaccia, J. C. Atherton, J. M. Reyrat, R. Rappuoli, and J. L. Telford. 2000. Cell specificity of Helicobacter pylori cytotoxin is determined by a short region in the polymorphic midregion. Infect. Immun.68:3754-3757.
  • 294. Johansson, E. L., C. Bergquist, A. Edebo, C. Johansson, and A. M. Svennerholm. 2004. Comparison of different routes of vaccination for eliciting antibody responses in the human stomach. Vaccine22:984-990. [[PubMed]
  • 295. Johnson-Delaney, CA. 2005. The ferret gastrointestinal tract and Helicobacter mustelae infection. Vet. Clin. N. Am. Exot. Anim. Pract.8:197-212. [[PubMed][Google Scholar]
  • 296. Jones, A. C., R. P. Logan, S. Foynes, A. Cockayne, B. W. Wren, and C. W. Penn. 1997. A flagellar sheath protein of Helicobacter pylori is identical to HpaA, a putative N-acetylneuraminyllactose-binding hemagglutinin, but is not an adhesin for AGS cells. J. Bacteriol.179:5643-5647.
  • 297. Josenhans, C., R. L. Ferrero, A. Labigne, and S. Suerbaum. 1999. Cloning and allelic exchange mutagenesis of two flagellin genes of Helicobacter felis. Mol. Microbiol.33:350-362. [[PubMed]
  • 298. Kabir, S. 2004. Detection of Helicobacter pylori DNA in feces and saliva by polymerase chain reaction: a review. Helicobacter9:115-123. [[PubMed]
  • 299. Kansau, I., F. Guillain, J. M. Thiberge, and A. Labigne. 1996. Nickel binding and immunological properties of the C-terminal domain of the Helicobacter pylori GroES homologue (HspA). Mol. Microbiol.22:1013-1023. [[PubMed]
  • 300. Kansau, I., J. Raymond, E. Bingen, P. Courcoux, N. Kalach, M. Bergeret, N. Briami, C. Dupont, and A. Labigne. 1996. Genotyping of Helicobacter pylori isolates by sequencing of PCR products and comparison with the RAPD technique. Res. Microbiol.147:661-669. [[PubMed]
  • 301. Karhukorpi, J., Y. Yan, S. Niemela, J. Valtonen, P. Koistinen, T. Joensuu, P. Saikku, and R. Karttunen. 2002. Effect of CD14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD14. Clin. Exp. Immunol.128:326-332.
  • 302. Karita, M., T. Kouchiyama, K. Okita, and T. Nakazawa. 1991. New small animal model for human gastric Helicobacter pylori infection: success in both nude and euthymic mice. Am. J. Gastroenterol.86:1596-1603. [[PubMed]
  • 303. Karttunen, R. A., T. J. Karttunen, M. M. Yousfi, H. M. el-Zimaity, D. Y. Graham, and F. A. el-Zaatari. 1997. Expression of mRNA for interferon-gamma, interleukin-10, and interleukin-12 (p40) in normal gastric mucosa and in mucosa infected with Helicobacter pylori. Scand. J. Gastroenterol.32:22-27. [[PubMed]
  • 304. Kato, S., M. Onda, N. Matsukura, A. Tokunaga, N. Matsuda, K. Yamashita, and P. G. Shields. 1996. Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients. An age and gender matched case-control study. Cancer77:1654-1661. [[PubMed]
  • 305. Kato, S., M. Onda, N. Matsukura, A. Tokunaga, N. Matsuda, K. Yamashita, and P. G. Shields. 1997. Helicobacter pylori infection and genetic polymorphisms for cancer-related genes in gastric carcinogenesis. Biomed. Pharmacother.51:145-149. [[PubMed]
  • 306. Kavermann, H., B. P. Burns, K. Angermuller, S. Odenbreit, W. Fischer, K. Melchers, and R. Haas. 2003. Identification and characterization of Helicobacter pylori genes essential for gastric colonization. J. Exp. Med.197:813-822.
  • 307. Kawahara, T., Y. Kuwano, S. Teshima-Kondo, T. Kawai, T. Nikawa, K. Kishi, and K. Rokutan. 2001. Toll-like receptor 4 regulates gastric pit cell responses to Helicobacter pylori infection. J. Med. Investig.48:190-197. [[PubMed]
  • 308. Keates, S., A. C. Keates, M. Warny, R. M. Peek, Jr., P. G. Murray, and C. P. Kelly. 1999. Differential activation of mitogen-activated protein kinases in AGS gastric epithelial cells by cag+ and cagHelicobacter pylori. J. Immunol.163:5552-5559. [[PubMed]
  • 309. Keenan, J. I., S. G. Rijpkema, Z. Durrani, and J. A. Roake. 2003. Differences in immunogenicity and protection in mice and guinea pigs following intranasal immunization with Helicobacter pylori outer membrane antigens. FEMS Immunol. Med. Microbiol.36:199-205. [[PubMed]
  • 310. Keller, W. C., and P. Michetti. 2001. Vaccination against Helicobacter pylori—an old companion of man. Expert Opin. Biol. Ther.1:795-802. [[PubMed]
  • 311. Kelly, DJ. 2001. The physiology and metabolism of Campylobacter jejuni and Helicobacter pylori. Symp. Ser. Soc. Appl. Microbiol.2001:16S-24S. [[PubMed][Google Scholar]
  • 312. Kelly, DJ. 1998. The physiology and metabolism of the human gastric pathogen Helicobacter pylori. Adv. Microb. Physiol.40:137-189. [[PubMed][Google Scholar]
  • 313. Kidd, M., R. M. Peek, A. J. Lastovica, D. A. Israel, A. F. Kummer, and J. A. Louw. 2001. Analysis of iceA genotypes in South African Helicobacter pylori strains and relationship to clinically significant disease. Gut49:629-635.
  • 314. Kim, S., A. K. Chamberlain, and J. U. Bowie. 2004. Membrane channel structure of Helicobacter pylori vacuolating toxin: role of multiple GXXXG motifs in cylindrical channels. Proc. Natl. Acad. Sci. USA101:5988-5991.
  • 315. Kita, T., Y. Tanigawara, N. Aoyama, T. Hohda, Y. Saijoh, F. Komada, T. Sakaeda, K. Okumura, T. Sakai, and M. Kasuga. 2001. CYP2C19 genotype related effect of omeprazole on intragastric pH and antimicrobial stability. Pharm. Res.18:615-621. [[PubMed]
  • 316. Kivi, M., Y. Tindberg, M. Sorberg, T. H. Casswall, R. Befrits, P. M. Hellstrom, C. Bengtsson, L. Engstrand, and M. Granstrom. 2003. Concordance of Helicobacter pylori strains within families. J. Clin. Microbiol.41:5604-5608.
  • 317. Kobayashi, H., S. Kamiya, T. Suzuki, K. Kohda, S. Muramatsu, T. Kurumada, U. Ohta, M. Miyazawa, N. Kimura, N. Mutoh, T. Shirai, A. Takagi, S. Harasawa, N. Tani, and T. Miwa. 1996. The effect of Helicobacter pylori on gastric acid secretion by isolated parietal cells from a guinea pig. Association with production of vacuolating toxin by H. pylori. Scand. J. Gastroenterol.31:428-433. [[PubMed]
  • 318. Kodama, M., K. Murakami, A. Nishizono, and T. Fujioka. 2004. Animal models for the study of Helicobacter-induced gastric carcinoma. J. Infect. Chemother.10:316-325. [[PubMed]
  • 319. Koenig, W., N. Khuseyinova, M. M. Hoffmann, W. Marz, M. Frohlich, A. Hoffmeister, H. Brenner, and D. Rothenbacher. 2002. CD14 C(−260)→T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease. J. Am. Coll. Cardiol.40:34-42. [[PubMed]
  • 320. Konno, M., N. Fujii, S. Yokota, K. Sato, M. Takahashi, E. Mino, and T. Sugiyama. 2005. Five-year follow-up study of mother-to-child transmission of Helicobacter pylori infection detected by a random amplified polymorphic DNA fingerprinting method. J. Clin. Microbiol.43:2246-2250.
  • 321. Korhonen, H., E. L. Syvaoja, H. Ahola-Luttila, S. Sivela, S. Kopola, J. Husu, and T. U. Kosunen. 1995. Bactericidal effect of bovine normal and immune serum, colostrum and milk against Helicobacter pylori. J. Appl. Bacteriol.78:655-662. [[PubMed]
  • 322. Kosunen, T. U., A. Aromaa, P. Knekt, A. Salomaa, H. Rautelin, P. Lohi, and O. P. Heinonen. 1997. Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol. Infect.119:29-34.
  • 323. Krakowka, S., K. A. Eaton, and R. D. Leunk. 1998. Antimicrobial therapies for Helicobacter pylori infection in gnotobiotic piglets. Antimicrob. Agents Chemother.42:1549-1554.
  • 324. Krakowka, S., K. A. Eaton, and D. M. Rings. 1995. Occurrence of gastric ulcers in gnotobiotic piglets colonized by Helicobacter pylori. Infect. Immun.63:2352-2355.
  • 325. Krakowka, S., D. R. Morgan, W. G. Kraft, and R. D. Leunk. 1987. Establishment of gastric Campylobacter pylori infection in the neonatal gnotobiotic piglet. Infect. Immun.55:2789-2796.
  • 326. Krakowka, S., S. S. Ringler, K. A. Eaton, W. B. Green, and R. Leunk. 1996. Manifestations of the local gastric immune response in gnotobiotic piglets infected with Helicobacter pylori. Vet. Immunol. Immunopathol.52:159-173. [[PubMed]
  • 327. Kreiss, C., T. Buclin, M. Cosma, I. Corthesy-Theulaz, and P. Michetti. 1996. Safety of oral immunisation with recombinant urease in patients with Helicobacter pylori infection. Lancet347:1630-1631. [[PubMed]
  • 328. Krienitz, W. 1906. Ueber das auftreten von mageninhalt bei carcinoma ventriculi. Dtsch. Med. Wochenschr.22:872. [PubMed]
  • 329. Kuck, D., B. Kolmerer, C. Iking-Konert, P. H. Krammer, W. Stremmel, and J. Rudi. 2001. Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS. Infect. Immun.69:5080-5087.
  • 330. Kudo, T., Z. Z. Nurgalieva, M. E. Conner, S. Crawford, S. Odenbreit, R. Haas, D. Y. Graham, and Y. Yamaoka. 2004. Correlation between Helicobacter pylori OipA protein expression and oipA gene switch status. J. Clin. Microbiol.42:2279-2281.
  • 331. Kuipers, EJ. 1999. Review article: exploring the link between Helicobacter pylori and gastric cancer. Aliment. Pharmacol. Ther.13:3-12. [[PubMed][Google Scholar]
  • 332. Kuipers, EJ. 1998. Review article: relationship between Helicobacter pylori, atrophic gastritis and gastric cancer. Aliment. Pharmacol. Ther.12:25-36. [[PubMed][Google Scholar]
  • 333. Kuipers, E. J., D. A. Israel, J. G. Kusters, M. M. Gerrits, J. Weel, A. van Der Ende, R. W. van Der Hulst, H. P. Wirth, J. Hook-Nikanne, S. A. Thompson, and M. J. Blaser. 2000. Quasispecies development of Helicobacter pylori observed in paired isolates obtained years apart from the same host. J. Infect. Dis.181:273-282.
  • 334. Kuipers, E. J., L. Lundell, E. C. Klinkenberg-Knol, N. Havu, H. P. Festen, B. Liedman, C. B. Lamers, J. B. Jansen, J. Dalenback, P. Snel, G. F. Nelis, and S. G. Meuwissen. 1996. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N. Engl. J. Med.334:1018-1022. [[PubMed]
  • 335. Kuipers, E. J., G. F. Nelis, E. C. Klinkenberg-Knol, P. Snel, D. Goldfain, J. J. Kolkman, H. P. M. Festen, J. Dent, P. Zeitoun, N. Havu, M. Lamm, and A. Walan. 2004. Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long-term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Gut53:12-20.
  • 336. Kuipers, E. J., A. S. Pena, G. van Kamp, A. M. Uyterlinde, G. Pals, N. F. Pels, E. Kurz-Pohlmann, and S. G. Meuwissen. 1993. Seroconversion for Helicobacter pylori. Lancet342:328-331. [[PubMed]
  • 337. Kuipers, E. J., G. I. Perez-Perez, S. G. Meuwissen, and M. J. Blaser. 1995. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J. Natl. Cancer Inst.87:1777-1780. [[PubMed]
  • 338. Kuipers, E. J., J. C. Thijs, and H. P. Festen. 1995. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment. Pharmacol. Ther.9(Suppl. 2):59-69. [[PubMed]
  • 339. Kuipers, E. J., A. M. Uyterlinde, A. S. Pena, H. J. Hazenberg, E. Bloemena, J. Lindeman, E. C. Klinkenberg-Knol, and S. G. Meuwissen. 1995. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am. J. Gastroenterol.90:1401-1406. [[PubMed]
  • 340. Kuipers, E. J., A. M. Uyterlinde, A. S. Pena, R. Roosendaal, G. Pals, G. F. Nelis, H. P. Festen, and S. G. Meuwissen. 1995. Long-term sequelae of Helicobacter pylori gastritis. Lancet345:1525-1528. [[PubMed]
  • 341. Kurosawa, M., S. Kikuchi, Y. Inaba, T. Ishibashi, and F. Kobayashi. 2000. Helicobacter pylori infection among Japanese children. J. Gastroenterol. Hepatol.15:1382-1385. [[PubMed]
  • 342. Kusters, J. G., M. M. Gerrits, J. A. Van Strijp, and C. M. Vandenbroucke-Grauls. 1997. Coccoid forms of Helicobacter pylori are the morphologic manifestation of cell death. Infect. Immun.65:3672-3679.
  • 343. Kusters, J. G., and E. J. Kuipers. 1999. Helicobacter and atherosclerosis. Am. Heart J.138:S523-527. [[PubMed]
  • 344. Kusters, J. G., and E. J. Kuipers. 1998. Non-pylori Helicobacter infections in humans. Eur. J. Gastroenterol. Hepatol.10:239-241. [[PubMed]
  • 345. Kuwahara, H., Y. Miyamoto, T. Akaike, T. Kubota, T. Sawa, S. Okamoto, and H. Maeda. 2000. Helicobacter pylori urease suppresses bactericidal activity of peroxynitrite via carbon dioxide production. Infect. Immun.68:4378-4383.
  • 346. Kyriazanos, L. D., L. Ilias, V. Gizaris, P. Hountis, V. Georgaklis, A. Dafnopoulou, and K. Datsakis. 2001. Seroepidemiology of Helicobacter pylori infection in Hellenic Navy recruits. Eur. J. Epidemiol.17:501-504. [[PubMed]
  • 347. Labenz, J., A. L. Blum, E. Bayerdörffer, A. Meining, M. Stolte, and G. Börsch. 1997. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology112:1442-1447. [[PubMed]
  • 348. Labigne, A., V. Cussac, and P. Courcoux. 1991. Shuttle cloning and nucleotide sequences of Helicobacter pylori genes responsible for urease activity. J. Bacteriol.173:1920-1931.
  • 349. Lambert, J. R., and P. Midolo. 1997. The actions of bismuth in the treatment of Helicobacter pylori infection. Aliment. Pharmacol. Ther.11:27-33. [[PubMed]
  • 350. Laporte, R., P. Pernes, P. Pronnier, F. Gottrand, and P. Vincent. 2004. Acquisition of Helicobacter pylori infection after outbreaks of gastroenteritis: prospective cohort survey in institutionalised young people. BMJ329:204-205.
  • 351. Lavelle, J. P., S. Landas, F. A. Mitros, and J. L. Conklin. 1994. Acute gastritis associated with spiral organisms from cats. Dig. Dis. Sci.39:744-750. [[PubMed]
  • 352. Lee, A., J. G. Fox, G. Otto, and J. Murphy. 1990. A small animal model of human Helicobacter pylori active chronic gastritis. Gastroenterology99:1315-1323. [[PubMed]
  • 353. Lee, A., S. L. Hazell, J. O'Rourke, and S. Kouprach. 1988. Isolation of a spiral-shaped bacterium from the cat stomach. Infect. Immun.56:2843-2850.
  • 354. Lee, A., J. O'Rourke, M. C. De Ungria, B. Robertson, G. Daskalopoulos, and M. F. Dixon. 1997. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology112:1386-1397. [[PubMed]
  • 355. Lee, C. K., R. Weltzin, W. D. Thomas, Jr., H. Kleanthous, T. H. Ermak, G. Soman, J. E. Hill, S. K. Ackerman, and T. P. Monath. 1995. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J. Infect. Dis.172:161-172. [[PubMed]
  • 356. Lee, S. K., A. Stack, E. Katzowitsch, S. I. Aizawa, S. Suerbaum, and C. Josenhans. 2003. Helicobacter pylori flagellins have very low intrinsic activity to stimulate human gastric epithelial cells via TLR5. Microbes Infect.5:1345-1356. [[PubMed]
  • 357. Lehours, P., A. Menard, S. Dupouy, B. Bergey, F. Richy, F. Zerbib, A. Ruskone-Fourmestraux, J. C. Delchier, and F. Megraud. 2004. Evaluation of the association of nine Helicobacter pylori virulence factors with strains involved in low-grade gastric mucosa-associated lymphoid tissue lymphoma. Infect. Immun.72:880-888.
  • 358. Leontiades, G. I., V. K. Sharma, and C. W. Howden. 1999. Non-gastrointestinal tract associations of Helicobacter pylori infection: what is the evidence? Arch. Intern. Med.159:925-940. [[PubMed]
  • 359. Lepper, P. M., A. Moricke, K. Vogt, G. Bode, and M. Trautmann. 2004. Comparison of different criteria for interpretation of immunoglobulin G immunoblotting results for diagnosis of Helicobacter pylori infection. Clin. Diagn. Lab Immunol.11:569-576.
  • 360. Leung, W. K., S. R. Lin, J. Y. Ching, K. F. To, E. K. Ng, F. K. Chan, J. Y. Lau, and J. J. Sung. 2004. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut53:1244-1249.
  • 361. Leung, W. K., K. L. Siu, C. K. Kwok, S. Y. Chan, R. Sung, and J. J. Sung. 1999. Isolation of Helicobacter pylori from vomitus in children and its implication in gastro-oral transmission. Am. J. Gastroenterol.94:2881-2884. [[PubMed]
  • 362. Leunk, RD. 1991. Production of a cytotoxin by Helicobacter pylori. Rev. Infect. Dis.13(Suppl. 8):S686-S689. [[PubMed][Google Scholar]
  • 363. Leunk, R. D., P. T. Johnson, B. C. David, W. G. Kraft, and D. R. Morgan. 1988. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J. Med. Microbiol.26:93-99. [[PubMed]
  • 364. Ley, C., A. Mohar, J. Guarner, R. Herrera-Goepfert, L. S. Figueroa, D. Halperin, I. Johnstone, and J. Parsonnet. 2004. Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial. Cancer Epidemiol. Biomarkers Prev.13:4-10. [[PubMed]
  • 365. Li, C., B. Xia, Y. Yang, J. Li, and H. H. Xia. 2005. TNF gene polymorphisms and Helicobacter pylori infection in gastric carcinogenesis in Chinese population. Am. J. Gastroenterol.100:290-294. [[PubMed]
  • 366. Linden, S., T. Boren, A. Dubois, and I. Carlstedt. 2004. Rhesus monkey gastric mucins: oligomeric structure, glycoforms and Helicobacter pylori binding. Biochem. J.379:765-775.
  • 367. Linden, S., H. Nordman, J. Hedenbro, M. Hurtig, T. Boren, and I. Carlstedt. 2002. Strain- and blood group-dependent binding of Helicobacter pylori to human gastric MUC5AC glycoforms. Gastroenterology123:1923-1930. [[PubMed]
  • 368. Lindholm, C., M. Quiding-Jarbrink, H. Lonroth, A. Hamlet, and A. M. Svennerholm. 1998. Local cytokine response in Helicobacter pylori-infected subjects. Infect. Immun.66:5964-5971.
  • 369. Lingwood, C. A., G. Wasfy, H. Han, and M. Huesca. 1993. Receptor affinity purification of a lipid-binding adhesin from Helicobacter pylori. Infect. Immun.61:2474-2478.
  • 370. Liu, C. C., C. L. Lee, C. C. Chan, T. C. Tu, C. C. Liao, C. H. Wu, and T. K. Chen. 2003. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study. Arch. Intern. Med.163:2020-2024. [[PubMed]
  • 371. Liu, H., H. Ye, A. Ruskone-Fourmestraux, D. De Jong, S. Pileri, C. Thiede, A. Lavergne, H. Boot, G. Caletti, T. Wundisch, T. Molina, B. G. Taal, S. Elena, T. Thomas, P. L. Zinzani, A. Neubauer, M. Stolte, R. A. Hamoudi, A. Dogan, P. G. Isaacson, and M. Q. Du. 2002. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology122:1286-1294. [[PubMed]
  • 372. Logan, RP. 1998. Urea breath tests in the management of Helicobacter pylori infection. Gut43(Suppl. 1):S47-S50. [Google Scholar]
  • 373. Lorca, G. L., T. Wadstrom, G. F. Valdez, and A. Ljungh. 2001. Lactobacillus acidophilus autolysins inhibit Helicobacter pylori in vitro. Curr. Microbiol.42:39-44. [[PubMed]
  • 374. Lozniewski, A., X. Haristoy, D. A. Rasko, R. Hatier, F. Plenat, D. E. Taylor, and K. Angioi-Duprez. 2003. Influence of Lewis antigen expression by Helicobacter pylori on bacterial internalization by gastric epithelial cells. Infect. Immun.71:2902-2906.
  • 375. Lu, C. C., B. S. Sheu, T. W. Chen, H. B. Yang, K. H. Hung, A. W. Kao, C. H. Chuang, and J. J. Wu. 2005. Host TNF-alpha-1031 and -863 promoter single nucleotide polymorphisms determine the risk of benign ulceration after H. pylori infection. Am. J. Gastroenterol.100:1274-1282. [[PubMed]
  • 376. Lu, H., P. I. Hsu, D. Y. Graham, and Y. Yamaoka. 2005. Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology128:833-848.
  • 377. Lu, W., K. Pan, L. Zhang, D. Lin, X. Miao, and W. You. 2005. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor alpha and risk of gastric cancer in a Chinese population. Carcinogenesis26:631-636. [[PubMed]
  • 378. Lu, Y., T. E. Redlinger, R. Avitia, A. Galindo, and K. Goodman. 2002. Isolation and genotyping of Helicobacter pylori from untreated municipal wastewater. Appl. Environ. Microbiol.68:1436-1439.
  • 379. Luger, A. 1917. Ueber spirochaeten und fusiforme bazillen im darm, mit einer beitrag zur frage der lamblien-enteritis. Wiein. Klin. Wochenschr.52:1643-1647. [PubMed]
  • 380. Lupetti, P., J. E. Heuser, R. Manetti, P. Massari, S. Lanzavecchia, P. L. Bellon, R. Dallai, R. Rappuoli, and J. L. Telford. 1996. Oligomeric and subunit structure of the Helicobacter pylori vacuolating cytotoxin. J. Cell Biol.133:801-807.
  • 381. Macarthur, M., G. L. Hold, and E. M. El-Omar. 2004. Inflammation and cancer. II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am. J. Physiol. Gastrointest. Liver Physiol.286:G515-G520. [[PubMed]
  • 382. Macdonald, TT. 2001. The worm turns on Helicobacter pylori. Gut48:10-11. [Google Scholar]
  • 383. Machado, J. C., C. Figueiredo, P. Canedo, P. Pharoah, R. Carvalho, S. Nabais, C. Castro Alves, M. L. Campos, L. J. Van Doorn, C. Caldas, R. Seruca, F. Carneiro, and M. Sobrinho-Simoes. 2003. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology125:364-371. [[PubMed]
  • 384. Maeda, S., M. Akanuma, Y. Mitsuno, Y. Hirata, K. Ogura, H. Yoshida, Y. Shiratori, and M. Omata. 2001. Distinct mechanism of Helicobacter pylori-mediated NF-kappa B activation between gastric cancer cells and monocytic cells. J. Biol. Chem.276:44856-44864. [[PubMed]
  • 385. Maeda, S., H. Yoshida, T. Ikenoue, K. Ogura, F. Kanai, N. Kato, Y. Shiratori, and M. Omata. 1999. Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates. Gut44:336-341.
  • 386. Mahdavi, J., T. Boren, C. Vandenbroucke-Grauls, and B. J. Appelmelk. 2003. Limited role of lipopolysaccharide Lewis antigens in adherence of Helicobacter pylori to the human gastric epithelium. Infect. Immun.71:2876-2880.
  • 387. Mahdavi, J., B. Sonden, M. Hurtig, F. O. Olfat, L. Forsberg, N. Roche, J. Angstrom, T. Larsson, S. Teneberg, K. A. Karlsson, S. Altraja, T. Wadstrom, D. Kersulyte, D. E. Berg, A. Dubois, C. Petersson, K. E. Magnusson, T. Norberg, F. Lindh, B. B. Lundskog, A. Arnqvist, L. Hammarstrom, and T. Boren. 2002. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science297:573-578.
  • 388. Malaty, H. M., L. Engstrand, N. L. Pedersen, and D. Y. Graham. 1994. Helicobacter pylori infection: genetic and environmental influences. A study of twins. Ann. Intern. Med.120:982-986. [[PubMed]
  • 389. Malaty, H. M., and D. Y. Graham. 1994. Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection. Gut35:742-745.
  • 390. Malaty, H. M., D. Y. Graham, W. A. Wattigney, S. R. Srinivasan, M. Osato, and G. S. Berenson. 1999. Natural history of Helicobacter pylori infection in childhood: 12-year follow-up cohort study in a biracial community. Clin. Infect. Dis.28:279-282. [[PubMed]
  • 391. Mandell, L., A. P. Moran, A. Cocchiarella, J. Houghton, N. Taylor, J. G. Fox, T. C. Wang, and E. A. Kurt-Jones. 2004. Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via Toll-like receptor 2 but not Toll-like receptor 4. Infect. Immun.72:6446-6454.
  • 392. Marais, A., G. L. Mendz, S. L. Hazell, and F. Megraud. 1999. Metabolism and genetics of Helicobacter pylori: the genome era. Microbiol. Mol. Biol. Rev.63:642-674.
  • 393. Marchetti, M., B. Arico, D. Burroni, N. Figura, R. Rappuoli, and P. Ghiara. 1995. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science267:1655-1658. [[PubMed]
  • 394. Marcus, E. A., A. P. Moshfegh, G. Sachs, and D. R. Scott. 2005. The periplasmic α-carbonic anhydrase activity of Helicobacter pylori is essential for acid acclimation. J. Bacteriol.187:729-738.
  • 395. Marcus, E. A., and D. R. Scott. 2001. Cell lysis is responsible for the appearance of extracellular urease in Helicobacter pylori. Helicobacter6:93-99. [[PubMed]
  • 396. Marnila, P., S. Rokka, L. Rehnberg-Laiho, P. Karkkainen, T. U. Kosunen, H. Rautelin, M. L. Hanninen, E. L. Syvaoja, and H. Korhonen. 2003. Prevention and suppression of Helicobacter felis infection in mice using colostral preparation with specific antibodies. Helicobacter8:192-201. [[PubMed]
  • 397. Marshall, B. J., J. A. Armstrong, G. J. Francis, N. T. Nokes, and S. H. Wee. 1987. Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis. Digestion37(Suppl. 2):16-30. [[PubMed]
  • 398. Marshall, B. J., J. A. Armstrong, D. B. McGechie, and R. J. Glancy. 1985. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med. J. Austr.142:436-439. [[PubMed]
  • 399. Marshall, B. J., D. B. McGechie, P. A. Rogers, and R. J. Glancy. 1985. Pyloric campylobacter infection and gastroduodenal disease. Med. J. Austr.142:439-444. [[PubMed]
  • 400. Reference deleted.
  • 401. Marshall, B. J., and J. R. Warren. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lanceti:1311-1315. [[PubMed]
  • 402. Matsumoto, S., Y. Washizuka, Y. Matsumoto, S. Tawara, F. Ikeda, Y. Yokota, and M. Karita. 1997. Induction of ulceration and severe gastritis in Mongolian gerbil by Helicobacter pylori infection. J. Med. Microbiol.46:391-397. [[PubMed]
  • 403. Mattapallil, J. J., S. Dandekar, D. R. Canfield, and J. V. Solnick. 2000. A predominant Th1 type of immune response is induced early during acute Helicobacter pylori infection in rhesus macaques. Gastroenterology118:307-315. [[PubMed]
  • 404. Maurer, K. J., M. M. Ihrig, A. B. Rogers, V. Ng, G. Bouchard, M. R. Leonard, M. C. Carey, and J. G. Fox. 2005. Identification of cholelithogenic enterohepatic helicobacter species and their role in murine cholesterol gallstone formation. Gastroenterology128:1023-1033. [[PubMed]
  • 405. Maurer, K. J., A. B. Rogers, Z. Ge, A. J. Wiese, M. C. Carey, and J. G. Fox. 2006. Helicobacter pylori and cholesterol gallstone formation in C57L/J mice: a prospective study. Am. J. Physiol. Gastrointest. Liver Physiol.290:G175-G182. [[PubMed]
  • 406. McGee, D. J., F. J. Radcliff, G. L. Mendz, R. L. Ferrero, and H. L. Mobley. 1999. Helicobacter pylori rocF is required for arginase activity and acid protection in vitro but is not essential for colonization of mice or for urease activity. J. Bacteriol.181:7314-7322.
  • 407. McGowan, C. C., A. Necheva, S. A. Thompson, T. L. Cover, and M. J. Blaser. 1998. Acid-induced expression of an LPS-associated gene in Helicobacter pylori. Mol. Microbiol.30:19-31. [[PubMed]
  • 408. Megraud, F. 2004. Basis for the management of drug-resistant Helicobacter pylori infection. Drugs64:1893-1904. [[PubMed]
  • 409. Megraud, F. 1995. Rationale for the choice of antibiotics for the eradication of Helicobacter pylori. Eur. J. Gastroenterol. Hepatol.7(Suppl. 1):S49-S54. [[PubMed]
  • 410. Megraud, F. 2000. Strategies to treat patients with antibiotic resistant Helicobacter pylori. Int. J. Antimicrob. Agents16:507-509. [[PubMed]
  • 411. Mégraud, F. 1995. Transmission of Helicobacter pylori: faecal-oral versus oral-oral. Aliment. Pharmacol. Ther.9:85-91. [[PubMed]
  • 412. Megraud, F., and HLamouliatte. 2003. Review article: the treatment of refractory Helicobacter pylori infection. Aliment. Pharmacol. Ther.17:1333-1343. [[PubMed][Google Scholar]
  • 413. Mehta, N., S. Benoit, and R. J. Maier. 2003. Roles of conserved nucleotide-binding domains in accessory proteins, HypB and UreG, in the maturation of nickel-enzymes required for efficient Helicobacter pylori colonization. Microb. Pathog.35:229-234. [[PubMed]
  • 414. Mehta, N., J. W. Olson, and R. J. Maier. 2003. Characterization of Helicobacter pylori nickel metabolism accessory proteins needed for maturation of both urease and hydrogenase. J. Bacteriol.185:726-734.
  • 415. Mehta, N. S., S. Benoit, J. V. Mysore, R. S. Sousa, and R. J. Maier. 2005. Helicobacter hepaticus hydrogenase mutants are deficient in hydrogen-supported amino acid uptake and in causing liver lesions in A/J mice. Infect. Immun.73:5311-5318.
  • 416. Melchers, K., L. Herrmann, F. Mauch, D. Bayle, D. Heuermann, T. Weitzenegger, A. Schuhmacher, G. Sachs, R. Haas, G. Bode, K. Bensch, and K. P. Schafer. 1998. Properties and function of the P type ion pumps cloned from Helicobacter pylori. Acta Physiol. Scand. Suppl.643:123-135. [[PubMed]
  • 417. Mellgard, B., S. Arvidsson, A. Lee, G. Sundell, and H. Larsson. 1994. Helicobacter felis infected rat as a model for Helicobacter pylori infection, colonisation pattern and inflammatory response. Am. J. Gastroenterol.89:1320. [PubMed]
  • 418. Mendz, G. L., and S. L. Hazell. 1996. The urea cycle of Helicobacter pylori. Microbiology142:2959-2967. [[PubMed]
  • 419. Mendz, G. L., E. M. Holmes, and R. L. Ferrero. 1998. In situ characterization of Helicobacter pylori arginase. Biochim. Biophys. Acta1388:465-477. [[PubMed]
  • 420. Mendz, G. L., A. J. Shepley, S. L. Hazell, and M. A. Smith. 1997. Purine metabolism and the microaerophily of Helicobacter pylori. Arch. Microbiol.168:448-456. [[PubMed]
  • 421. Mera, R., E. T. Fontham, L. E. Bravo, J. C. Bravo, M. B. Piazuelo, M. C. Camargo, and P. Correa. 2005. Long term follow up of patients treated for Helicobacter pylori infection. Gut54:1536-1540.
  • 422. Merrell, D. S., M. L. Goodrich, G. Otto, L. S. Tompkins, and S. Falkow. 2003. pH-regulated gene expression of the gastric pathogen Helicobacter pylori. Infect. Immun.71:3529-3539.
  • 423. Merrell, D. S., L. J. Thompson, C. C. Kim, H. Mitchell, L. S. Tompkins, A. Lee, and S. Falkow. 2003. Growth phase-dependent response of Helicobacter pylori to iron starvation. Infect. Immun.71:6510-6525.
  • 424. Meyer, F., K. T. Wilson, and S. P. James. 2000. Modulation of innate cytokine responses by products of Helicobacter pylori. Infect. Immun.68:6265-6272.
  • 425. Michetti, P., C. Kreiss, K. L. Kotloff, N. Porta, J. L. Blanco, D. Bachmann, M. Herranz, P. F. Saldinger, I. Corthesy-Theulaz, G. Losonsky, R. Nichols, J. Simon, M. Stolte, S. Ackerman, T. P. Monath, and A. L. Blum. 1999. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology116:804-812. [[PubMed]
  • 426. Midolo, P. D., J. R. Lambert, R. Hull, F. Luo, and M. L. Grayson. 1995. In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J. Appl. Bacteriol.79:475-479. [[PubMed]
  • 427. Moayyedi, P., S. Soo, J. Deeks, B. Delaney, A. Harris, M. Innes, R. Oakes, S. Wilson, A. Roalfe, C. Bennett, and D. Forman. 2005. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst. Rev.2005:CD002096. [[PubMed]
  • 428. Mobley, H. L., R. M. Garner, and P. Bauerfeind. 1995. Helicobacter pylori nickel-transport gene nixA: synthesis of catalytically active urease in Escherichia coli independent of growth conditions. Mol. Microbiol.16:97-109. [[PubMed]
  • 429. Mobley, H. L., R. M. Garner, G. R. Chippendale, J. V. Gilbert, A. V. Kane, and A. G. Plaut. 1999. Role of Hpn and NixA of Helicobacter pylori in susceptibility and resistance to bismuth and other metal ions. Helicobacter4:162-169. [[PubMed]
  • 430. Mobley, H. L., M. D. Island, and R. P. Hausinger. 1995. Molecular biology of microbial ureases. Microbiol. Rev.59:451-480.
  • 431. Moese, S., M. Selbach, T. Kwok, V. Brinkmann, W. Konig, T. F. Meyer, and S. Backert. 2004. Helicobacter pylori induces AGS cell motility and elongation via independent signaling pathways. Infect. Immun.72:3646-3649.
  • 432. Mohammadi, M., S. Czinn, R. Redline, and J. Nedrud. 1996. Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J. Immunol.156:4729-4738. [[PubMed]
  • 433. Mohammadi, M., J. Nedrud, R. Redline, N. Lycke, and S. J. Czinn. 1997. Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology113:1848-1857. [[PubMed]
  • 434. Molinari, M., C. Galli, M. de Bernard, N. Norais, J. M. Ruysschaert, R. Rappuoli, and C. Montecucco. 1998. The acid activation of Helicobacter pylori toxin VacA: structural and membrane binding studies. Biochem. Biophys. Res. Commun.248:334-340. [[PubMed]
  • 435. Molinari, M., M. Salio, C. Galli, N. Norais, R. Rappuoli, A. Lanzavecchia, and C. Montecucco. 1998. Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. J. Exp. Med.187:135-140.
  • 436. Montecucco, C., and Mde Bernard. 2003. Molecular and cellular mechanisms of action of the vacuolating cytotoxin (VacA) and neutrophil-activating protein (HP-NAP) virulence factors of Helicobacter pylori. Microbes Infect.5:715-721. [[PubMed][Google Scholar]
  • 437. Monteiro, M. A., K. H. Chan, D. A. Rasko, D. E. Taylor, P. Y. Zheng, B. J. Appelmelk, H. P. Wirth, M. Yang, M. J. Blaser, S. O. Hynes, A. P. Moran, and M. B. Perry. 1998. Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides. Molecular mimicry between H. pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. J. Biol. Chem.273:11533-11543. [[PubMed]
  • 438. Montemurro, P., G. Barbuti, W. G. Dundon, G. Del Giudice, R. Rappuoli, M. Colucci, P. De Rinaldis, C. Montecucco, N. Semeraro, and E. Papini. 2001. Helicobacter pylori neutrophil-activating protein stimulates tissue factor and plasminogen activator inhibitor-2 production by human blood mononuclear cells. J. Infect. Dis.183:1055-1062. [[PubMed]
  • 439. Montemurro, P., H. Nishioka, W. G. Dundon, M. de Bernard, G. Del Giudice, R. Rappuoli, and C. Montecucco. 2002. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a potent stimulant of mast cells. Eur. J. Immunol.32:671-676. [[PubMed]
  • 440. Moran, A. P., Y. A. Knirel, S. N. Senchenkova, G. Widmalm, S. O. Hynes, and P. E. Jansson. 2002. Phenotypic variation in molecular mimicry between Helicobacter pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. Acid-induced phase variation in Lewis and Lewis expression by H. pylori lipopolysaccharides. J. Biol. Chem.277:5785-5795. [[PubMed]
  • 441. Mori, N., A. M. Krensky, R. Geleziunas, A. Wada, T. Hirayama, C. Sasakawa, and N. Yamamoto. 2003. Helicobacter pylori induces RANTES through activation of NF-κB. Infect. Immun.71:3748-3756.
  • 442. Morris, A., and GNicholson. 1987. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am. J. Gastroenterol.82:192-199. [[PubMed][Google Scholar]
  • 443. Morris, A. J., M. R. Ali, G. I. Nicholson, G. I. Perez-Perez, and M. J. Blaser. 1991. Long-term follow-up of voluntary ingestion of Helicobacter pylori. Ann. Intern. Med.114:662-663. [[PubMed]
  • 444. Munson, L., J. W. Nesbit, D. G. Meltzer, L. P. Colly, L. Bolton, and N. P. Kriek. 1999. Diseases of captive cheetahs (Acinonyx jubatus jubatus) in South Africa: a 20-year retrospective survey. J. Zoo Wildl. Med.30:342-347. [[PubMed]
  • 445. Munzenmaier, A., C. Lange, E. Glocker, A. Covacci, A. Moran, S. Bereswill, P. A. Baeuerle, M. Kist, and H. L. Pahl. 1997. A secreted/shed product of Helicobacter pylori activates transcription factor nuclear factor-kappa B. J. Immunol.159:6140-6147. [[PubMed]
  • 446. Muotiala, A., I. M. Helander, L. Pyhala, T. U. Kosunen, and A. P. Moran. 1992. Low biological activity of Helicobacter pylori lipopolysaccharide. Infect. Immun.60:1714-1716.
  • 447. Murakami, K., T. Fujioka, M. Kodama, S. Honda, T. Okimoto, T. Oda, A. Nishizono, R. Sato, T. Kubota, J. Kagawa, and M. Nasu. 2002. Analysis of p53 mutations and Helicobacter pylori infection in human and animal models. J. Gastroenterol.37(Suppl. 13):1-5. [[PubMed]
  • 448. Mysore, J. V., T. Wigginton, P. M. Simon, D. Zopf, L. M. Heman-Ackah, and A. Dubois. 1999. Treatment of Helicobacter pylori infection in rhesus monkeys using a novel antiadhesion compound. Gastroenterology117:1316-1325. [[PubMed]
  • 449. Nakagawa, S., T. Osaki, Y. Fujioka, H. Yamaguchi, and S. Kamiya. 2005. Long-term infection of Mongolian gerbils with Helicobacter pylori: microbiological, histopathological, and serological analyses. Clin. Diagn. Lab. Immunol.12:347-353.
  • 450. Nakamura, H., H. Yoshiyama, H. Takeuchi, T. Mizote, K. Okita, and T. Nakazawa. 1998. Urease plays an important role in the chemotactic motility of Helicobacter pylori in a viscous environment. Infect. Immun.66:4832-4837.
  • 451. Nakamura, S., T. Matsumoto, H. Suekane, H. Matsumoto, M. Esaki, T. Yao, and M. Iida. 2005. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment. Cancer104:532-540. [[PubMed]
  • 452. Namavar, F., M. Sparrius, E. C. I. Veerman, B. J. Appelmelk, and C. M. J. E. Vandenbroucke-Grauls. 1998. Neutrophil-activating protein mediates adhesion of Helicobacter pylori to sulfated carbohydrates on high-molecular-weight salivary mucin. Infect. Immun.66:444-447.
  • 453. Reference deleted.
  • 454. Naumann, M. 2005. Pathogenicity island-dependent effects of Helicobacter pylori on intracellular signal transduction in epithelial cells. Int. J. Med. Microbiol.295:335-341. [[PubMed]
  • 455. Naumann, M., S. Wessler, C. Bartsch, B. Wieland, A. Covacci, R. Haas, and T. F. Meyer. 1999. Activation of activator protein 1 and stress response kinases in epithelial cells colonized by Helicobacter pylori encoding the cag pathogenicity island. J. Biol. Chem.274:31655-31662. [[PubMed]
  • 456. Nedenskov, P. 1994. Nutritional requirements for growth of Helicobacter pylori. Appl. Environ. Microbiol.60:3450-3453.
  • 457. Neu, B., P. Randlkofer, M. Neuhofer, P. Voland, A. Mayerhofer, M. Gerhard, W. Schepp, and C. Prinz. 2002. Helicobacter pylori induces apoptosis of rat gastric parietal cells. Am. J. Physiol. Gastrointest. Liver Physiol.283:G309-G318. [[PubMed]
  • 458. Nishi, T., K. Okazaki, K. Kawasaki, T. Fukui, H. Tamaki, M. Matsuura, M. Asada, T. Watanabe, K. Uchida, N. Watanabe, H. Nakase, M. Ohana, H. Hiai, and T. Chiba. 2003. Involvement of myeloid dendritic cells in the development of gastric secondary lymphoid follicles in Helicobacter pylori-infected neonatally thymectomized BALB/c mice. Infect. Immun.71:2153-2162.
  • 459. Nolan, K. J., D. J. McGee, H. M. Mitchell, T. Kolesnikow, J. M. Harro, J. O'Rourke, J. E. Wilson, S. J. Danon, N. D. Moss, H. L. Mobley, and A. Lee. 2002. In vivo behavior of a Helicobacter pylori SS1 nixA mutant with reduced urease activity. Infect. Immun.70:685-691.
  • 460. Nomura, A., G. N. Stemmermann, P. H. Chyou, G. I. Perez-Perez, and M. J. Blaser. 1994. Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann. Intern. Med.120:977-981. [[PubMed]
  • 461. Nomura, S., H. Suzuki, T. Masaoka, K. Kurabayashi, H. Ishii, M. Kitajima, K. Nomoto, and T. Hibi. 2005. Effect of dietary anti-urease immunoglobulin Y on Helicobacter pylori infection in Mongolian gerbils. Helicobacter10:43-52. [[PubMed]
  • 462. Occhialini, A., A. Marais, R. Alm, F. Garcia, R. Sierra, and F. Megraud. 2000. Distribution of open reading frames of plasticity region of strain J99 in Helicobacter pylori strains isolated from gastric carcinoma and gastritis patients in Costa Rica. Infect. Immun.68:6240-6249.
  • 463. Occhialini, A., A. Marais, M. Urdaci, R. Sierra, N. Munoz, A. Covacci, and F. Megraud. 2001. Composition and gene expression of the cag pathogenicity island in Helicobacter pylori strains isolated from gastric carcinoma and gastritis patients in Costa Rica. Infect. Immun.69:1902-1908.
  • 464. O'Croinin, T., M. Clyne, B. J. Appelmelk, and B. Drumm. 2001. Antigastric autoantibodies in ferrets naturally infected with Helicobacter mustelae. Infect. Immun.69:2708-2713.
  • 465. O'Croinin, T., M. Clyne, and B. Drumm. 1998. Molecular mimicry of ferret gastric epithelial blood group antigen A by Helicobacter mustelae. Gastroenterology114:690-696. [[PubMed]
  • 466. Oda, T., K. Murakami, A. Nishizono, M. Kodama, M. Nasu, and T. Fujioka. 2002. Long-term Helicobacter pylori infection in Japanese monkeys induces atrophic gastritis and accumulation of mutations in the p53 tumor suppressor gene. Helicobacter7:143-151. [[PubMed]
  • 467. Odenbreit, S., G. Faller, and R. Haas. 2002. Role of the alpAB proteins and lipopolysaccharide in adhesion of Helicobacter pylori to human gastric tissue. Int. J. Med. Microbiol.292:247-256. [[PubMed]
  • 468. Odenbreit, S., B. Gebert, J. Puls, W. Fischer, and R. Haas. 2001. Interaction of Helicobacter pylori with professional phagocytes: role of the cag pathogenicity island and translocation, phosphorylation and processing of CagA. Cell. Microbiol.3:21-31. [[PubMed]
  • 469. Odenbreit, S., J. Puls, B. Sedlmaier, E. Gerland, W. Fischer, and R. Haas. 2000. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science287:1497-1500. [[PubMed]
  • 470. Odenbreit, S., M. Till, D. Hofreuter, G. Faller, and R. Haas. 1999. Genetic and functional characterization of the alpAB gene locus essential for the adhesion of Helicobacter pylori to human gastric tissue. Mol. Microbiol.31:1537-1548. [[PubMed]
  • 471. Ogura, K., S. Maeda, M. Nakao, T. Watanabe, M. Tada, T. Kyutoku, H. Yoshida, Y. Shiratori, and M. Omata. 2000. Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil. J. Exp. Med.192:1601-1610.
  • 472. Ohyama, I., N. Ohmiya, Y. Niwa, K. Shirai, A. Taguchi, A. Itoh, Y. Hirooka, K. Wakai, N. Hamajima, N. Mori, and H. Goto. 2004. The association between tumour necrosis factor-alpha gene polymorphism and the susceptibility to rugal hyperplastic gastritis and gastric carcinoma. Eur. J. Gastroenterol. Hepatol.16:693-700. [[PubMed]
  • 473. Olczak, A. A., J. W. Olson, and R. J. Maier. 2002. Oxidative-stress resistance mutants of Helicobacter pylori. J. Bacteriol.184:3186-3193.
  • 474. Olczak, A. A., R. W. Seyler, Jr., J. W. Olson, and R. J. Maier. 2003. Association of Helicobacter pylori antioxidant activities with host colonization proficiency. Infect. Immun.71:580-583.
  • 475. O'Rourke, J., A. Lee, and J. G. Fox. 1992. An ultrastructural study of Helicobacter mustelae and evidence of a specific association with gastric mucosa. J. Med. Microbiol.36:420-427. [[PubMed]
  • 476. O'Rourke, J. L., M. F. Dixon, A. Jack, A. Enno, and A. Lee. 2004. Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma in an animal model of ‘Helicobacter heilmannii’ infection. J. Pathol.203:896-903. [[PubMed]
  • 477. O'Rourke, J. L., and A. Lee. 2003. Animal models of Helicobacter pylori infection and disease. Microbes Infect.5:741-748. [[PubMed]
  • 478. O'Rourke, J. L., J. V. Solnick, B. A. Neilan, K. Seidel, R. Hayter, L. M. Hansen, and A. Lee. 2004. Description of ‘Candidatus Helicobacter heilmannii’ based on DNA sequence analysis of 16S rRNA and urease genes. Int. J. Syst. Evol. Microbiol.54:2203-2211. [[PubMed]
  • 479. Oshima, T., H. Aiba, Y. Masuda, S. Kanaya, M. Sugiura, B. L. Wanner, H. Mori, and T. Mizuno. 2002. Transcriptome analysis of all two-component regulatory system mutants of Escherichia coli K-12. Mol. Microbiol.46:281-291. [[PubMed]
  • 480. Ota, H., J. Nakayama, M. Momose, M. Hayama, T. Akamatsu, T. Katsuyama, D. Y. Graham, and R. M. Genta. 1998. Helicobacter pylori infection produces reversible glycosylation changes to gastric mucins. Virchows Arch.433:419-426. [[PubMed]
  • 481. O'Toole, P. W., M. C. Lane, and S. Porwollik. 2000. Helicobacter pylori motility. Microbes Infect.2:1207-1214. [[PubMed]
  • 482. Owen, R. J., S. Sharp, A. J. Lawson, Z. Durrani, S. Rijpkema, and M. Kidd. 2003. Investigation of the biological relevance of Helicobacter pylori cagE locus diversity, presence of CagA tyrosine phosphorylation motifs and vacuolating cytotoxin genotype on IL-8 induction in gastric epithelial cells. FEMS Immunol. Med. Microbiol.36:135-140. [[PubMed]
  • 483. Pagliaccia, C., X. M. Wang, F. Tardy, J. L. Telford, J. M. Ruysschaert, and V. Cabiaux. 2000. Structure and interaction of VacA of Helicobacter pylori with a lipid membrane. Eur. J. Biochem.267:104-109. [[PubMed]
  • 484. Palli, D., C. Saieva, S. Gemma, G. Masala, M. J. Gomez-Miguel, I. Luzzi, M. D'Errico, G. Matullo, G. Ozzola, R. Manetti, G. Nesi, F. Sera, I. Zanna, E. Dogliotti, and E. Testai. 2005. GSTT1 and GSTM1 gene polymorphisms and gastric cancer in a high-risk italian population. Int. J. Cancer115:284-289. [[PubMed]
  • 485. Pappo, J., D. Torrey, L. Castriotta, A. Savinainen, Z. Kabok, and A. Ibraghimov. 1999. Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions. Infect. Immun.67:337-341.
  • 486. Parente, F., C. Cucino, and G. Bianchi Porro. 2003. Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts. Dig. Liver Dis.35:523-528. [[PubMed]
  • 487. Parkin, DM. 2001. Global cancer statistics in the year 2000. Lancet Oncol.2:533-543. [[PubMed][Google Scholar]
  • 488. Parsonnet, J. 1995. The incidence of Helicobacter pylori infection. Aliment. Pharmacol. Ther.9(Suppl. 2):45-51. [[PubMed]
  • 489. Parsonnet, J., G. D. Friedman, N. Orentreich, and H. Vogelman. 1997. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut40:297-301.
  • 490. Parsonnet, J., S. Hansen, L. Rodriguez, A. B. Gelb, R. A. Warnke, E. Jellum, N. Orentreich, J. H. Vogelman, and G. D. Friedman. 1994. Helicobacter pylori infection and gastric lymphoma. N. Engl. J. Med.330:1267-1271. [[PubMed]
  • 491. Parsonnet, J., and P. G. Isaacson. 2004. Bacterial infection and MALT lymphoma. N. Engl. J. Med.350:213-215. [[PubMed]
  • 492. Parsonnet, J., H. Shmuely, and T. Haggerty. 1999. Fecal and oral shedding of Helicobacter pylori from healthy infected adults. JAMA282:2240-2245. [[PubMed]
  • 493. Paster, B. J., A. Lee, J. G. Fox, F. E. Dewhirst, L. A. Tordoff, G. J. Fraser, J. L. O'Rourke, N. S. Taylor, and R. Ferrero. 1991. Phylogeny of Helicobacter felis sp. nov., Helicobacter mustelae, and related bacteria. Int. J. Syst. Bacteriol.41:31-38. [[PubMed]
  • 494. Paziak-Domanska, B., M. Chmiela, A. Jarosinska, and W. Rudnicka. 2000. Potential role of CagA in the inhibition of T cell reactivity in Helicobacter pylori infections. Cell. Immunol.202:136-139. [[PubMed]
  • 495. Peek, R. M., Jr., S. A. Thompson, J. P. Donahue, K. T. Tham, J. C. Atherton, M. J. Blaser, and G. G. Miller. 1998. Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc. Assoc. Am. Physicians110:531-544. [[PubMed]
  • 496. Peek, R. M., G. G. Miller, K. T. Tham, G. I. Pérez-Pérez, X. M. Zhao, J. C. Atherton, and M. J. Blaser. 1995. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab. Investig.73:760-770. [[PubMed]
  • 497. Pel, PK. 1899. Diseases of the stomach. De Erven Bohn, Amsterdam, The Netherlands. (In Dutch.)
  • 498. Pelicic, V., J. M. Reyrat, L. Sartori, C. Pagliaccia, R. Rappuoli, J. L. Telford, C. Montecucco, and E. Papini. 1999. Helicobacter pylori VacA cytotoxin associated with the bacteria increases epithelial permeability independently of its vacuolating activity. Microbiology145:2043-2050. [[PubMed]
  • 499. Perez-Perez, G. I., A. Z. Olivares, F. Y. Foo, S. Foo, A. J. Neusy, C. Ng, R. S. Holzman, M. Marmor, and M. J. Blaser. 2005. Seroprevalence of Helicobacter pylori in New York City populations originating in East Asia. J. Urban Health82:510-516.
  • 500. Perez-Perez, G. I., D. Rothenbacher, and H. Brenner. 2004. Epidemiology of Helicobacter pylori infection. Helicobacter9(Suppl. 1):1-6. [[PubMed]
  • 501. Perez-Perez, G. I., R. B. Sack, R. Reid, M. Santosham, J. Croll, and M. J. Blaser. 2003. Transient and persistent Helicobacter pylori colonization in Native American children. J. Clin. Microbiol.41:2401-2407.
  • 502. Perri, F., V. Festa, and A. Andriulli. 1998. Treatment of antibiotic-resistant Helicobacter pylori. N. Engl. J. Med.339:53. [[PubMed]
  • 503. Perri, F., V. Festa, R. Clemente, M. Quitadamo, and A. Andriulli. 2000. Rifabutin-based ‘rescue therapy’ for Helicobacter pylori infected patients after failure of standard regimens. Aliment. Pharmacol. Ther.14:311-316. [[PubMed]
  • 504. Peterson, W. L., D. Y. Graham, B. Marshall, M. J. Blaser, R. M. Genta, P. D. Klein, C. W. Stratton, J. Drnec, P. Prokocimer, and N. Siepman. 1993. Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am. J. Gastroenterol.88:1860-1864. [[PubMed]
  • 505. Pflock, M., P. Dietz, J. Schar, and D. Beier. 2004. Genetic evidence for histidine kinase HP165 being an acid sensor of Helicobacter pylori. FEMS Microbiol. Lett.234:51-61. [[PubMed]
  • 506. Pflock, M., S. Kennard, I. Delany, V. Scarlato, and D. Beier. 2005. Acid-induced activation of the urease promoters is mediated directly by the ArsRS two-component system of Helicobacter pylori. Infect. Immun.73:6437-6445.
  • 507. Phadnis, S. H., M. H. Parlow, M. Levy, D. Ilver, C. M. Caulkins, J. B. Connors, and B. E. Dunn. 1996. Surface localization of Helicobacter pylori urease and a heat shock protein homolog requires bacterial autolysis. Infect. Immun.64:905-912.
  • 508. Poms, R. E., and S. R. Tatini. 2001. Survival of Helicobacter pylori in ready-to-eat foods at 4 degrees C. Int. J. Food Microbiol.63:281-286. [[PubMed]
  • 509. Pot, R. G., J. G. Kusters, L. C. Smeets, W. Van Tongeren, C. M. Vandenbroucke-Grauls, and A. Bart. 2001. Interspecies transfer of antibiotic resistance between Helicobacter pylori and Helicobacter acinonychis. Antimicrob. Agents Chemother.45:2975-2976.
  • 510. Pounder, R. E., and D. Ng. 1995. The prevalence of Helicobacter pylori infection in different countries. Aliment. Pharmacol. Ther.9:33-39. [[PubMed]
  • 511. Prinz, C., M. Schoniger, R. Rad, I. Becker, E. Keiditsch, S. Wagenpfeil, M. Classen, T. Rosch, W. Schepp, and M. Gerhard. 2001. Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Cancer Res.61:1903-1909. [[PubMed]
  • 512. Pritchard, D. M., and S. M. Przemeck. 2004. Review article: how useful are the rodent animal models of gastric adenocarcinoma? Aliment. Pharmacol. Ther.19:841-859. [[PubMed]
  • 513. Queiroz, D. M., J. B. Guerra, G. A. Rocha, A. M. Rocha, A. Santos, A. G. De Oliveira, M. M. Cabral, A. M. Nogueira, and C. A. De Oliveira. 2004. IL1B and IL1RN polymorphic genes and Helicobacter pylori cagA strains decrease the risk of reflux esophagitis. Gastroenterology127:73-79. [[PubMed]
  • 514. Queralt, N., R. Bartolome, and R. Araujo. 2005. Detection of Helicobacter pylori DNA in human faeces and water with different levels of faecal pollution in the north-east of Spain. J. Appl. Microbiol.98:889-895. [[PubMed]
  • 515. Rad, R., A. Dossumbekova, B. Neu, R. Lang, S. Bauer, D. Saur, M. Gerhard, and C. Prinz. 2004. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut53:1082-1089.
  • 516. Rad, R., M. Gerhard, R. Lang, M. Schoniger, T. Rosch, W. Schepp, I. Becker, H. Wagner, and C. Prinz. 2002. The Helicobacter pylori blood group antigen-binding adhesin facilitates bacterial colonization and augments a nonspecific immune response. J. Immunol.168:3033-3041. [[PubMed]
  • 517. Rad, R., C. Prinz, B. Neu, M. Neuhofer, M. Zeitner, P. Voland, I. Becker, W. Schepp, and M. Gerhard. 2003. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J. Infect. Dis.188:272-281. [[PubMed]
  • 518. Raderer, M., B. Streubel, S. Woehrer, A. Puespoek, U. Jaeger, M. Formanek, and A. Chott. 2005. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin. Cancer Res.11:3349-3352. [[PubMed]
  • 519. Raghavan, S., M. Fredriksson, A. M. Svennerholm, J. Holmgren, and E. Suri-Payer. 2003. Absence of CD4+CD25+ regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice. Clin. Exp. Immunol.132:393-400.
  • 520. Ramarao, N., S. D. Gray-Owen, S. Backert, and T. F. Meyer. 2000. Helicobacter pylori inhibits phagocytosis by professional phagocytes involving type IV secretion components. Mol. Microbiol.37:1389-1404. [[PubMed]
  • 521. Ramarao, N., and T. F. Meyer. 2001. Helicobacter pylori resists phagocytosis by macrophages: quantitative assessment by confocal microscopy and fluorescence-activated cell sorting. Infect. Immun.69:2604-2611.
  • 522. Rauws, E. A. J., and G. N. J. Tytgat. 1990. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet335:1233-1235. [[PubMed]
  • 523. Raymond, J., J. M. Thiberg, C. Chevalier, N. Kalach, M. Bergeret, A. Labigne, and C. Dauga. 2004. Genetic and transmission analysis of Helicobacter pylori strains within a family. Emerg. Infect. Dis.10:1816-1821.
  • 524. Rehnberg-Laiho, L., H. Rautelin, P. Koskela, S. Sarna, E. Pukkala, A. Aromaa, P. Knekt, and T. U. Kosunen. 2001. Decreasing prevalence of helicobacter antibodies in Finland, with reference to the decreasing incidence of gastric cancer. Epidemiol. Infect.126:37-42.
  • 525. Rensing, C., and GGrass. 2003. Escherichia coli mechanisms of copper homeostasis in a changing environment. FEMS Microbiol. Rev.27:197-213. [[PubMed][Google Scholar]
  • 526. Reynolds, D. J., and C. W. Penn. 1994. Characteristics of Helicobacter pylori growth in a defined medium and determination of its amino acid requirements. Microbiology140:2649-2656. [[PubMed]
  • 527. Rieder, G., J. L. Merchant, and R. Haas. 2005. Helicobacter pylori cag-type IV secretion system facilitates corpus colonization to induce precancerous conditions in Mongolian gerbils. Gastroenterology128:1229-1242. [[PubMed]
  • 528. Rijpkema, S. G., Z. Durrani, G. Beavan, J. R. Gibson, J. Luck, R. J. Owen, and G. R. Auda. 2001. Analysis of host responses of guinea pigs during Helicobacter pylori infection. FEMS Immunol. Med. Microbiol.30:151-156. [[PubMed]
  • 529. Roche, N., J. Angstrom, M. Hurtig, T. Larsson, T. Boren, and S. Teneberg. 2004. Helicobacter pylori and complex gangliosides. Infect. Immun.72:1519-1529.
  • 530. Rollinson, S., A. P. Levene, F. K. Mensah, P. L. Roddam, J. M. Allan, T. C. Diss, E. Roman, A. Jack, K. MacLennan, M. F. Dixon, and G. J. Morgan. 2003. Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity. Blood102:1007-1011. [[PubMed]
  • 531. Roosendaal, R., E. J. Kuipers, J. Buitenwerf, C. van Uffelen, S. G. Meuwissen, G. J. van Kamp, and C. M. Vandenbroucke-Grauls. 1997. Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am. J. Gastroenterol.92:1480-1482. [[PubMed]
  • 532. Rowland, M., L. Daly, M. Vaughan, A. Higgins, B. Bourke, and B. Drumm. 2006. Age-specific incidence of Helicobacter pylori. Gastroenterology130:65-72. [[PubMed]
  • 533. Ruiz, B., P. Correa, E. T. H. Fontham, and T. Ramakrishnan. 1996. Antral atrophy, Helicobacter pylori colonization, and gastric pH. Am. J. Clin. Pathol.105:96-101. [[PubMed]
  • 534. Russell, R. J., D. C. Haines, M. R. Anver, J. K. Battles, P. L. Gorelick, L. L. Blumenauer, M. A. Gonda, and J. M. Ward. 1995. Use of antibiotics to prevent hepatitis and typhlitis in male scid mice spontaneously infected with Helicobacter hepaticus. Lab. Anim. Sci.45:373-378. [[PubMed]
  • 535. Sachs, G., D. Scott, D. Weeks, and K. Melchers. 2002. The compartment buffered by the urease of Helicobacter pylori: cytoplasm or periplasm? Trends Microbiol.10:217-218. [[PubMed]
  • 536. Sachs, G., D. L. Weeks, Y. Wen, E. A. Marcus, D. R. Scott, and K. Melchers. 2005. Acid acclimation by Helicobacter pylori. Physiology (Bethesda)20:429-438. [[PubMed]
  • 537. Sagar, M., L. Bertilsson, M. Stridsberg, A. Kjellin, S. Mardh, and R. Seensalu. 2000. Omeprazole and CYP2C19 polymorphism: effects of long-term treatment on gastrin, pepsinogen I, and chromogranin A in patients with acid related disorders. Aliment. Pharmacol. Ther.14:1495-1502. [[PubMed]
  • 538. Sagar, M., G. Tybring, M. L. Dahl, L. Bertilsson, and R. Seensalu. 2000. Effects of omeprazole on intragastric pH and plasma gastrin are dependent on the CYP2C19 polymorphism. Gastroenterology119:670-676. [[PubMed]
  • 539. Reference deleted.
  • 540. Sakamoto, I., M. Igarashi, K. Kimura, A. Takagi, T. Miwa, and Y. Koga. 2001. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J. Antimicrob. Chemother.47:709-710. [[PubMed]
  • 541. Sakamoto, S., T. Watanabe, T. Tokumaru, H. Takagi, H. Nakazato, and K. O. Lloyd. 1989. Expression of Lewis a, Lewis b, Lewis x, Lewis y, sialyl-Lewis a, and sialyl-Lewis x blood group antigens in human gastric carcinoma and in normal gastric tissue. Cancer Res.49:745-752. [[PubMed]
  • 542. Salama, N. R., G. Otto, L. Tompkins, and S. Falkow. 2001. Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection. Infect. Immun.69:730-736.
  • 543. Saldinger, P. F., N. Porta, P. Launois, J. A. Louis, G. A. Waanders, H. Bouzourene, P. Michetti, A. L. Blum, and I. E. Corthesy-Theulaz. 1998. Immunization of BALB/c mice with Helicobacter urease B induces a T helper 2 response absent in Helicobacter infection. Gastroenterology115:891-897. [[PubMed]
  • 544. Sanaka, M., Y. Kuyama, M. Yamanaka, and M. Iwasaki. 1999. Decrease in serum concentrations of Helicobacter pylori IgG antibodies during antituberculosis therapy: the possible eradication by rifampicin and streptomycin. Am. J. Gastroenterol.94:1983-1984. [[PubMed]
  • 545. Santos, A., D. M. Queiroz, A. Menard, A. Marais, G. A. Rocha, C. A. Oliveira, A. M. Nogueira, M. Uzeda, and F. Megraud. 2003. New pathogenicity marker found in the plasticity region of the Helicobacter pylori genome. J. Clin. Microbiol.41:1651-1655.
  • 546. Scarlato, V., I. Delany, G. Spohn, and D. Beier. 2001. Regulation of transcription in Helicobacter pylori: simple systems or complex circuits? Int. J. Med. Microbiol.291:107-117. [[PubMed]
  • 547. Schade, C., G. Flemstrom, and L. Holm. 1994. Hydrogen ion concentration in the mucus layer on top of acid-stimulated and -inhibited rat gastric mucosa. Gastroenterology107:180-188. [[PubMed]
  • 548. Schenk, B. E., E. J. Kuipers, G. F. Nelis, E. Bloemena, J. C. Thijs, P. Snel, A. E. G. Luckers, E. C. Klinkenberg-Knol, H. P. M. Festen, P. P. Viergever, J. Lindeman, and S. G. M. Meuwissen. 2000. Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy. Gut46:615-621.
  • 549. Schmid, E. N., G. von Recklinghausen, and R. Ansorg. 1990. Bacteriophages in Helicobacter (Campylobacter) pylori. J. Med. Microbiol.32:101-104. [[PubMed]
  • 550. Schreiber, S., R. Bucker, C. Groll, M. Azevedo-Vethacke, D. Garten, P. Scheid, S. Friedrich, S. Gatermann, C. Josenhans, and S. Suerbaum. 2005. Rapid loss of motility of Helicobacter pylori in the gastric lumen in vivo. Infect. Immun.73:1584-1589.
  • 551. Schreiber, S., M. Konradt, C. Groll, P. Scheid, G. Hanauer, H. O. Werling, C. Josenhans, and S. Suerbaum. 2004. The spatial orientation of Helicobacter pylori in the gastric mucus. Proc. Natl. Acad. Sci. USA101:5024-5029.
  • 552. Schwizer, W., M. Thumshirn, J. Dent, I. Guldenschuh, D. Menne, G. Cathomas, and M. Fried. 2001. Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial. Lancet357:1738-1742. [[PubMed]
  • 553. Scott, D. R., E. A. Marcus, D. L. Weeks, A. Lee, K. Melchers, and G. Sachs. 2000. Expression of the Helicobacter pylori ureI gene is required for acidic pH activation of cytoplasmic urease. Infect. Immun.68:470-477.
  • 554. Scott, D. R., E. A. Marcus, D. L. Weeks, and G. Sachs. 2002. Mechanisms of acid resistance due to the urease system of Helicobacter pylori. Gastroenterology123:187-195. [[PubMed]
  • 555. Segal, E. D., J. Cha, J. Lo, S. Falkow, and L. S. Tompkins. 1999. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc. Natl. Acad. Sci. USA96:14559-14564.
  • 556. Selbach, M., S. Moese, S. Backert, P. R. Jungblut, and T. F. Meyer. 2004. The Helicobacter pylori CagA protein induces tyrosine dephosphorylation of ezrin. Proteomics4:2961-2968. [[PubMed]
  • 557. Selbach, M., S. Moese, C. R. Hauck, T. F. Meyer, and S. Backert. 2002. Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J. Biol. Chem.277:6775-6778. [[PubMed]
  • 558. Selbach, M., S. Moese, R. Hurwitz, C. R. Hauck, T. F. Meyer, and S. Backert. 2003. The Helicobacter pylori CagA protein induces cortactin dephosphorylation and actin rearrangement by c-Src inactivation. EMBO J.22:515-528.
  • 559. Serpa, J., R. Almeida, C. Oliveira, F. S. Silva, E. Silva, C. Reis, J. Le Pendu, G. Oliveira, L. M. Ribeiro, and L. David. 2003. Lewis enzyme (alpha1-3/4 fucosyltransferase) polymorphisms do not explain the Lewis phenotype in the gastric mucosa of a Portuguese population. J. Hum. Genet.48:183-189. [[PubMed]
  • 560. Setiawan, V. W., Z. F. Zhang, G. P. Yu, Q. Y. Lu, Y. L. Li, M. L. Lu, M. R. Wang, C. H. Guo, S. Z. Yu, R. C. Kurtz, and C. C. Hsieh. 2001. GSTP1 polymorphisms and gastric cancer in a high-risk Chinese population. Cancer Causes Control12:673-681. [[PubMed]
  • 561. Seyler, R. W., Jr., J. W. Olson, and R. J. Maier. 2001. Superoxide dismutase-deficient mutants of Helicobacter pylori are hypersensitive to oxidative stress and defective in host colonization. Infect. Immun.69:4034-4040.
  • 562. Shames, B., J. G. Fox, F. Dewhirst, L. Yan, Z. Shen, and N. S. Taylor. 1995. Identification of widespread Helicobacter hepaticus infection in feces in commercial mouse colonies by culture and PCR assay. J. Clin. Microbiol.33:2968-2972.
  • 563. Sharma, V. K., A. V. Sahai, F. A. Corder, and C. W. Howden. 2001. Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage. Aliment. Pharmacol. Ther.15:1939-1947. [[PubMed]
  • 564. Shimizu, N., K. Inada, H. Nakanishi, T. Tsukamoto, Y. Ikehara, M. Kaminishi, S. Kuramoto, A. Sugiyama, T. Katsuyama, and M. Tatematsu. 1999. Helicobacter pylori infection enhances glandular stomach carcinogenesis in Mongolian gerbils treated with chemical carcinogens. Carcinogenesis20:669-676. [[PubMed]
  • 565. Shomer, N. H., C. A. Dangler, M. T. Whary, and J. G. Fox. 1998. Experimental Helicobacter pylori infection induces antral gastritis and gastric mucosa-associated lymphoid tissue in guinea pigs. Infect. Immun.66:2614-2618.
  • 566. Simpson, K. W., P. L. McDonough, D. Strauss-Ayali, Y. F. Chang, P. Harpending, and B. A. Valentine. 1999. Helicobacter felis infection in dogs: effect on gastric structure and function. Vet. Pathol.36:237-248. [[PubMed]
  • 567. Simpson, K. W., D. Strauss-Ayali, P. L. McDonough, Y. F. Chang, and B. A. Valentine. 1999. Gastric function in dogs with naturally acquired gastric Helicobacter spp. infection. J. Vet. Intern. Med.13:507-515. [[PubMed]
  • 568. Simpson, K. W., D. Strauss-Ayali, E. Scanziani, R. K. Straubinger, P. L. McDonough, A. F. Straubinger, Y. F. Chang, C. Domeneghini, N. Arebi, and J. Calam. 2000. Helicobacter felis infection is associated with lymphoid follicular hyperplasia and mild gastritis but normal gastric secretory function in cats. Infect. Immun.68:779-790.
  • 569. Sinha, S. K., B. Martin, B. D. Gold, Q. Song, M. Sargent, and C. N. Bernstein. 2004. The incidence of Helicobacter pylori acquisition in children of a Canadian First Nations community and the potential for parent-to-child transmission. Helicobacter9:59-68. [[PubMed]
  • 570. Sipponen, P., M. Kekki, J. Haapakoski, T. Ihamaki, and M. Siurala. 1985. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int. J. Cancer35:173-177. [[PubMed]
  • 571. Sipponen, P., K. Varis, O. Fräki, U. M. Korri, K. Seppälä, and M. Siurala. 1990. Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis. Scand. J. Gastroenterol.25:966-973. [[PubMed]
  • 572. Sjunnesson, H., E. Sturegard, R. Willen, and T. Wadstrom. 2001. High intake of selenium, beta-carotene, and vitamins A, C, and E reduces growth of Helicobacter pylori in the guinea pig. Comp. Med.51:418-423. [[PubMed]
  • 573. Skirrow, MB. 1977. Campylobacter enteritis: a “new” disease. Br. Med. J.2:9-11. [Google Scholar]
  • 574. Skouloubris, S., A. Labigne, and H. De Reuse. 2001. The AmiE aliphatic amidase and AmiF formamidase of Helicobacter pylori: natural evolution of two enzyme paralogues. Mol. Microbiol.40:596-609. [[PubMed]
  • 575. Skouloubris, S., A. Labigne, and H. De Reuse. 1997. Identification and characterization of an aliphatic amidase in Helicobacter pylori. Mol. Microbiol.25:989-998. [[PubMed]
  • 576. Skouloubris, S., J. M. Thiberge, A. Labigne, and H. De Reuse. 1998. The Helicobacter pylori UreI protein is not involved in urease activity but is essential for bacterial survival in vivo. Infect. Immun.66:4517-4521.
  • 577. Slonczewski, J. L., D. J. McGee, J. Phillips, C. Kirkpatrick, and H. L. Mobley. 2000. pH-dependent protein profiles of Helicobacter pylori analyzed by two-dimensional gels. Helicobacter5:240-247. [[PubMed]
  • 578. Smith, M. A., and D. I. Edwards. 1995. The influence of microaerophilia and anaerobiosis on metronidazole uptake in Helicobacter pylori. J. Antimicrob. Chemother.36:453-461. [[PubMed]
  • 579. Smith, M. F., Jr., A. Mitchell, G. Li, S. Ding, A. M. Fitzmaurice, K. Ryan, S. Crowe, and J. B. Goldberg. 2003. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J. Biol. Chem.278:32552-32560. [[PubMed]
  • 580. Smoot, D. T., H. L. Mobley, G. R. Chippendale, J. F. Lewison, and J. H. Resau. 1990. Helicobacter pylori urease activity is toxic to human gastric epithelial cells. Infect. Immun.58:1992-1994.
  • 581. Smythies, L. E., K. B. Waites, J. R. Lindsey, P. R. Harris, P. Ghiara, and P. D. Smith. 2000. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice. J. Immunol.165:1022-1029. [[PubMed]
  • 582. Sobala, G. M., J. E. Crabtree, M. F. Dixon, C. J. Schorah, J. D. Taylor, B. J. Rathbone, R. V. Heatley, and A. T. R. Axon. 1991. Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations. Gut32:1415-1418.
  • 583. Solnick, JV. 2003. Clinical significance of Helicobacter species other than Helicobacter pylori. Clin. Infect. Dis.36:349-354. [[PubMed][Google Scholar]
  • 584. Solnick, J. V., D. R. Canfield, S. Yang, and J. Parsonnet. 1999. Rhesus monkey (Macaca mulatta) model of Helicobacter pylori: noninvasive detection and derivation of specific-pathogen-free monkeys. Lab. Anim. Sci.49:197-201. [[PubMed]
  • 585. Solnick, J. V., L. M. Hansen, N. R. Salama, J. K. Boonjakuakul, and M. Syvanen. 2004. Modification of Helicobacter pylori outer membrane protein expression during experimental infection of rhesus macaques. Proc. Natl. Acad. Sci. USA101:2106-2111.
  • 586. Solnick, J. V., J. O'Rourke, A. Lee, B. J. Paster, F. E. Dewhirst, and L. S. Tompkins. 1993. An uncultured gastric spiral organism is a newly identified Helicobacter in humans. J. Infect. Dis.168:379-385. [[PubMed]
  • 587. Solnick, J. V., and D. B. Schauer. 2001. Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases. Clin. Microbiol. Rev.14:59-97.
  • 588. Sommer, F., G. Faller, M. Rollinghoff, T. Kirchner, T. W. Mak, and M. Lohoff. 2001. Lack of gastritis and of an adaptive immune response in interferon regulatory factor-1-deficient mice infected with Helicobacter pylori. Eur. J. Immunol.31:396-402. [[PubMed]
  • 589. Sommer, F., H. Wilken, G. Faller, and M. Lohoff. 2004. Systemic Th1 immunization of mice against Helicobacter pylori infection with CpG oligodeoxynucleotides as adjuvants does not protect from infection but enhances gastritis. Infect. Immun.72:1029-1035.
  • 590. Sonnenberg, A. 1995. Temporal trends and geographical variations of peptic ulcer disease. Aliment. Pharmacol. Ther.9:3-12. [[PubMed]
  • 591. Sonnenberg, A. 1993. The US temporal and geographic variations of diseases related to Helicobacter pylori. Am. J. Public Health83:1006-1010.
  • 592. Sozzi, M., M. Crosatti, S. K. Kim, J. Romero, and M. J. Blaser. 2001. Heterogeneity of Helicobacter pylori cag genotypes in experimentally infected mice. FEMS Microbiol. Lett.203:109-114. [[PubMed]
  • 593. Stein, M., F. Bagnoli, R. Halenbeck, R. Rappuoli, W. J. Fantl, and A. Covacci. 2002. c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol. Microbiol.43:971-980. [[PubMed]
  • 594. Stein, M., R. Rappuoli, and A. Covacci. 2000. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc. Natl. Acad. Sci. USA97:1263-1268.
  • 595. Stingl, K., K. Altendorf, and E. P. Bakker. 2002. Acid survival of Helicobacter pylori: how does urease activity trigger cytoplasmic pH homeostasis? Trends Microbiol.10:70-74. [[PubMed]
  • 596. Stingl, K., and HDe Reuse. 2005. Staying alive overdosed: how does Helicobacter pylori control urease activity? Int. J. Med. Microbiol.295:307-315. [[PubMed][Google Scholar]
  • 597. Stoicov, C., M. Whary, A. B. Rogers, F. S. Lee, K. Klucevsek, H. Li, X. Cai, R. Saffari, Z. Ge, I. A. Khan, C. Combe, A. Luster, J. G. Fox, and J. Houghton. 2004. Coinfection modulates inflammatory responses and clinical outcome of Helicobacter felis and Toxoplasma gondii infections. J. Immunol.173:3329-3336. [[PubMed]
  • 598. Stolte, M., G. Kroher, A. Meining, A. Morgner, E. Bayerdörffer, and B. Bethke. 1997. A comparison of Helicobacter pylori and H. heilmannii gastritis. A matched control study involving 404 patients. Scand. J. Gastroenterol.32:28-33. [[PubMed]
  • 599. Stromberg, E., A. Lundgren, A. Edebo, S. Lundin, A. M. Svennerholm, and C. Lindholm. 2003. Increased frequency of activated T-cells in the Helicobacter pylori-infected antrum and duodenum. FEMS Immunol. Med. Microbiol.36:159-168. [[PubMed]
  • 600. Sturegard, E., H. Sjunnesson, B. Ho, R. Willen, P. Aleljung, H. C. Ng, and T. Wadstrom. 1998. Severe gastritis in guinea-pigs infected with Helicobacter pylori. J. Med. Microbiol.47:1123-1129. [[PubMed]
  • 601. Su, B., P. J. Ceponis, S. Lebel, H. Huynh, and P. M. Sherman. 2003. Helicobacter pylori activates Toll-like receptor 4 expression in gastrointestinal epithelial cells. Infect. Immun.71:3496-3502.
  • 602. Suerbaum, S., and MAchtman. 1999. Evolution of Helicobacter pylori: the role of recombination. Trends Microbiol.7:182-184. [[PubMed][Google Scholar]
  • 603. Suerbaum, S., and MAchtman. 2004. Helicobacter pylori: recombination, population structure and human migrations. Int. J. Med. Microbiol.294:133-139. [[PubMed][Google Scholar]
  • 604. Suerbaum, S., C. Josenhans, and A. Labigne. 1993. Cloning and genetic characterization of the Helicobacter pylori and Helicobacter mustelae flaB flagellin genes and construction of H. pylori flaA- and flaB-negative mutants by electroporation-mediated allelic exchange. J. Bacteriol.175:3278-3288.
  • 605. Suerbaum, S., C. Josenhans, T. Sterzenbach, B. Drescher, P. Brandt, M. Bell, M. Droge, B. Fartmann, H. P. Fischer, Z. Ge, A. Horster, R. Holland, K. Klein, J. Konig, L. Macko, G. L. Mendz, G. Nyakatura, D. B. Schauer, Z. Shen, J. Weber, M. Frosch, and J. G. Fox. 2003. The complete genome sequence of the carcinogenic bacterium Helicobacter hepaticus. Proc. Natl. Acad. Sci. USA100:7901-7906.
  • 606. Suerbaum, S., J. M. Smith, K. Bapumia, G. Morelli, N. H. Smith, E. Kunstmann, I. Dyrek, and M. Achtman. 1998. Free recombination within Helicobacter pylori. Proc. Natl. Acad. Sci. USA95:12619-12624.
  • 607. Sugiyama, A., F. Maruta, T. Ikeno, K. Ishida, S. Kawasaki, T. Katsuyama, N. Shimizu, and M. Tatematsu. 1998. Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil. Cancer Res.58:2067-2069. [[PubMed]
  • 608. Sunderman, F. W., S. M. Hopfer, K. R. Sweeney, A. H. Marcus, B. M. Most, and J. Creason. 1989. Nickel absorption and kinetics in human volunteers. Proc. Soc. Exp. Biol. Med.191:5-11. [[PubMed]
  • 609. Sundrud, M. S., V. J. Torres, D. Unutmaz, and T. L. Cover. 2004. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc. Natl. Acad. Sci. USA101:7727-7732.
  • 610. Sutton, P., J. Wilson, T. Kosaka, I. Wolowczuk, and A. Lee. 2000. Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies. Immunol. Cell Biol.78:28-30. [[PubMed]
  • 611. Suzuki, T., E. Grand, C. Bowman, J. L. Merchant, A. Todisco, L. Wang, and J. Del Valle. 2001. TNF-alpha and interleukin 1 activate gastrin gene expression via MAPK- and PKC-dependent mechanisms. Am. J. Physiol. Gastrointest. Liver Physiol.281:G1405-G1412. [[PubMed]
  • 612. Suzuki, T., M. Matsushima, A. Masui, K. Watanabe, A. Takagi, Y. Ogawa, T. Shirai, and T. Mine. 2005. Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura—a randomized controlled trial. Am. J. Gastroenterol.100:1265-1270. [[PubMed]
  • 613. Takata, T., E. El-Omar, M. Camorlinga, S. A. Thompson, Y. Minohara, P. B. Ernst, and M. J. Blaser. 2002. Helicobacter pylori does not require Lewis X or Lewis Y expression to colonize C3H/HeJ. mice. Infect. Immun.70:3073-3079.
  • 614. Take, S., M. Mizuno, K. Ishiki, Y. Nagahara, T. Yoshida, K. Yokota, K. Oguma, H. Okada, and Y. Shiratori. 2005. The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am. J. Gastroenterol.100:1037-1042. [[PubMed]
  • 615. Talley, N. J., and R. H. Hunt. 1997. What role does Helicobacter pylori play in dyspepsia and nonulcer dyspepsia? Arguments for and against H. pylori being associated with dyspeptic symptoms. Gastroenterology113:S67-S77. [[PubMed]
  • 616. Taneera, J., A. P. Moran, S. O. Hynes, H. O. Nilsson, W. Al-Soud, and T. Wadstrom. 2002. Influence of activated charcoal, porcine gastric mucin and beta-cyclodextrin on the morphology and growth of intestinal and gastric Helicobacter spp. Microbiology148:677-684. [[PubMed]
  • 617. Taneike, I., Y. Tamura, T. Shimizu, Y. Yamashiro, and T. Yamamoto. 2001. Helicobacter pylori intrafamilial infections: change in source of infection of a child from father to mother after eradication therapy. Clin. Diagn. Lab. Immunol.8:731-739.
  • 618. Tannaes, T., and GBukholm. 2005. Cholesteryl-6-O-acyl-alpha-D-glucopyranoside of Helicobacter pylori relate to relative lysophospholipid content. FEMS Microbiol. Lett.244:117-120. [[PubMed][Google Scholar]
  • 619. Tannaes, T., I. K. Bukholm, and G. Bukholm. 2005. High relative content of lysophospholipids of Helicobacter pylori mediates increased risk for ulcer disease. FEMS Immunol. Med. Microbiol.44:17-23. [[PubMed]
  • 620. Tannaes, T., N. Dekker, G. Bukholm, J. J. Bijlsma, and B. J. Appelmelk. 2001. Phase variation in the Helicobacter pylori phospholipase A gene and its role in acid adaptation. Infect. Immun.69:7334-7340.
  • 621. Telford, J. L., P. Ghiara, M. Dell'Orco, M. Comanducci, D. Burroni, M. Bugnoli, M. F. Tecce, S. Censini, A. Covacci, Z. Xiang, et al. 1994. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J. Exp. Med.179:1653-1658.
  • 622. Testerman, T. L., D. J. McGee, and H. L. Mobley. 2001. Helicobacter pylori growth and urease detection in the chemically defined medium Ham's F-12 nutrient mixture. J. Clin. Microbiol.39:3842-3850.
  • 623. The Eurogast Study Group. 1993. An international association between Helicobacter pylori infection and gastric cancer. Lancet341:1359-1362. [[PubMed]
  • 624. Thomas, J. E., J. E. Bunn, H. Kleanthous, T. P. Monath, M. Harding, W. A. Coward, and L. T. Weaver. 2004. Specific immunoglobulin A antibodies in maternal milk and delayed Helicobacter pylori colonization in Gambian infants. Clin. Infect. Dis.39:1155-1160. [[PubMed]
  • 625. Thompson, L. J., S. J. Danon, J. E. Wilson, J. L. O'Rourke, N. R. Salama, S. Falkow, H. Mitchell, and A. Lee. 2004. Chronic Helicobacter pylori infection with Sydney strain 1 and a newly identified mouse-adapted strain (Sydney strain 2000) in C57BL/6 and BALB/c mice. Infect. Immun.72:4668-4679.
  • 626. Thompson, L. J., D. S. Merrell, B. A. Neilan, H. Mitchell, A. Lee, and S. Falkow. 2003. Gene expression profiling of Helicobacter pylori reveals a growth-phase-dependent switch in virulence gene expression. Infect. Immun.71:2643-2655.
  • 627. Thong-Ngam, D., P. Tangkijvanich, P. Sampatanukul, P. Prichakas, V. Mahachai, and P. Tosukowong. 2005. Direct measurement of gastric H+/K+-ATPase activities in patients with or without Helicobacter pylori-associated chronic gastritis. World J. Gastroenterol.11:3514-3517.
  • 628. Tomb, J. F., O. White, A. R. Kerlavage, R. A. Clayton, G. G. Sutton, R. D. Fleischmann, K. A. Ketchum, H. P. Klenk, S. Gill, B. A. Dougherty, K. Nelson, J. Quackenbush, L. Zhou, E. F. Kirkness, S. Peterson, B. Loftus, D. Richardson, R. Dodson, H. G. Khalak, A. Glodek, K. McKenney, L. M. Fitzegerald, N. Lee, M. D. Adams, E. K. Hickey, D. E. Berg, J. D. Gocayne, T. R. Utterback, J. D. Peterson, J. M. Kelley, M. D. Cotton, J. M. Weidman, C. Fujii, C. Bowman, L. Watthey, E. Wallin, W. S. Hayes, M. Borodovsky, P. D. Karpk, H. O. Smith, C. M. Fraser, and J. C. Venter. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature388:539-547. [[PubMed]
  • 629. Tombola, F., C. Carlesso, I. Szabo, M. de Bernard, J. M. Reyrat, J. L. Telford, R. Rappuoli, C. Montecucco, E. Papini, and M. Zoratti. 1999. Helicobacter pylori vacuolating toxin forms anion-selective channels in planar lipid bilayers: possible implications for the mechanism of cellular vacuolation. Biophys. J.76:1401-1409.
  • 630. Tompkins, D. S., J. I. Wyatt, B. J. Rathbone, and A. P. West. 1988. The characterization and pathological significance of gastric Campylobacter-like organisms in the ferret: a model for chronic gastritis? Epidemiol. Infect.101:269-278.
  • 631. Tonello, F., W. G. Dundon, B. Satin, M. Molinari, G. Tognon, G. Grandi, G. del Guicide, R. Rappuoli, and C. Montecucco. 1999. The Helicobacter pylori neutrophil-activating protein is an iron-binding protein with dodecameric structure. Mol. Microbiol.34:238-246. [[PubMed]
  • 632. Torok, A. M., A. H. Bouton, and J. B. Goldberg. 2005. Helicobacter pylori induces interleukin-8 secretion by Toll-like receptor 2- and Toll-like receptor 5-dependent and -independent pathways. Infect. Immun.73:1523-1531.
  • 633. Torres, V. J., S. E. Ivie, M. S. McClain, and T. L. Cover. 2005. Functional properties of the p33 and p55 domains of the Helicobacter pylori vacuolating cytotoxin. J. Biol. Chem.280:21107-21114. [[PubMed]
  • 634. Treiber, G., and J. R. Lambert. 1998. The impact of Helicobacter pylori eradication on peptic ulcer healing. Am. J. Gastroenterol.93:1080-1084. [[PubMed]
  • 635. Tsai, C. J., S. Perry, L. Sanchez, and J. Parsonnet. 2005. Helicobacter pylori infection in different generations of Hispanics in the San Francisco Bay Area. Am. J. Epidemiol.162:351-357. [[PubMed]
  • 636. Tsutsumi, R., H. Higashi, M. Higuchi, M. Okada, and M. Hatakeyama. 2003. Attenuation of Helicobacter pylori CagA × SHP-2 signaling by interaction between CagA and C-terminal Src kinase. J. Biol. Chem.278:3664-3670. [[PubMed]
  • 637. Tummuru, M. K. R., T. L. Cover, and M. J. Blaser. 1993. Cloning and expression of a high molecular mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect. Immun.61:1799-1809.
  • 638. Uibo, R., T. Vorobjova, K. Metskula, K. Kisand, T. Wadstrom, and T. Kivik. 1995. Association of Helicobacter pylori and gastric autoimmunity: a population-based study. FEMS Immunol. Med. Microbiol.11:65-68. [[PubMed]
  • 639. Unemo, M., M. Aspholm-Hurtig, D. Ilver, J. Bergstrom, T. Boren, D. Danielsson, and S. Teneberg. 2005. The sialic acid binding SabA adhesin of Helicobacter pylori is essential for nonopsonic activation of human neutrophils. J. Biol. Chem.280:15390-15397. [[PubMed]
  • 640. Vaira, D., P. Malfertheiner, F. Megraud, A. T. Axon, M. Deltenre, A. M. Hirschl, G. Gasbarrini, C. O'Morain, J. M. Garcia, M. Quina, and G. N. Tytgat. 1999. Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. Lancet354:30-33. [[PubMed]
  • 641. Vakil, N., B. Hahn, and D. McSorley. 2000. Recurrent symptoms and gastro-oesophageal reflux disease patients with duodenal ulcer treated for Helicobacter pylori infection. Aliment. Pharmacol. Ther.14:45-51. [[PubMed]
  • 642. Valkonen, K. H., T. Wadstrom, and A. P. Moran. 1997. Identification of the N-acetylneuraminyllactose-specific laminin-binding protein of Helicobacter pylori. Infect. Immun.65:916-923.
  • 643. Van de Bovenkamp, J. H., J. Mahdavi, A. M. Korteland-Van Male, H. A. Buller, A. W. Einerhand, T. Boren, and J. Dekker. 2003. The MUC5AC glycoprotein is the primary receptor for Helicobacter pylori in the human stomach. Helicobacter8:521-532. [[PubMed]
  • 644. Van den Brink, G. R., K. M. Tytgat, R. W. Van der Hulst, C. M. Van der Loos, A. W. Einerhand, H. A. Buller, and J. Dekker. 2000. H. pylori colocalises with MUC5AC in the human stomach. Gut46:601-607.
  • 645. van der Ende, A., E. A. J. Rauws, M. Feller, C. J. J. Mulder, G. N. J. Tytgat, and J. Dankert. 1996. Heterogeneous Helicobacter pylori isolates from members of a family with a history of peptic ulcer disease. Gastroenterology111:638-647. [[PubMed]
  • 646. van der Hulst, R. W. M., E. A. J. Rauws, B. Köycü, J. J. Keller, F. J. W. ten Kate, J. Dankert, G. N. J. Tytgat, and A. van der Ende. 1997. Helicobacter pylori reinfection is virtually absent after successful eradication. J. Infect. Dis.176:196-200. [[PubMed]
  • 647. van Doorn, L. J., C. Figueiredo, R. Sanna, M. J. Blaser, and W. G. Quint. 1999. Distinct variants of Helicobacter pylori cagA are associated with vacA subtypes. J. Clin. Microbiol.37:2306-2311.
  • 648. van Doorn, L. J., C. Figueiredo, R. Sanna, S. Pena, P. Midolo, E. K. Ng, J. C. Atherton, M. J. Blaser, and W. G. Quint. 1998. Expanding allelic diversity of Helicobacter pylori vacA. J. Clin. Microbiol.36:2597-2603.
  • 649. van Doorn, L. J., C. Figueiredo, R. Sanna, A. Plaisier, P. Schneeberger, W. de Boer, and W. Quint. 1998. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology115:58-66. [[PubMed]
  • 650. Vanet, A., and ALabigne. 1998. Evidence for specific secretion rather than autolysis in the release of some Helicobacter pylori proteins. Infect. Immun.66:1023-1027. [Google Scholar]
  • 651. van Kooyk, Y., A. Engering, A. N. Lekkerkerker, I. S. Ludwig, and T. B. Geijtenbeek. 2004. Pathogens use carbohydrates to escape immunity induced by dendritic cells. Curr. Opin. Immunol.16:488-493. [[PubMed]
  • 652. van Leerdam, M. E., E. M. Vreeburg, E. A. Rauws, A. A. Geraedts, J. G. Tijssen, J. B. Reitsma, and G. N. Tytgat. 2003. Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. Am. J. Gastroenterol.98:1494-1499. [[PubMed]
  • 653. van Vliet, A. H. M., S. Bereswill, and J. G. Kusters. 2001. Ion metabolism and transport, p. 193-206. In H. L. T. Mobley, G. L. Mendz, and S. L. Hazell (ed.), Helicobacter pylori: physiology and genetics. ASM Press, Washington, D.C.
  • 654. van Vliet, A. H. M., E. J. Kuipers, J. Stoof, S. W. Poppelaars, and J. G. Kusters. 2004. Acid-responsive gene induction of ammonia-producing enzymes in Helicobacter pylori is mediated via a metal-responsive repressor cascade. Infect. Immun.72:766-773.
  • 655. van Vliet, A. H. M., E. J. Kuipers, B. Waidner, B. J. Davies, N. de Vries, C. W. Penn, C. M. Vandenbroucke-Grauls, M. Kist, S. Bereswill, and J. G. Kusters. 2001. Nickel-responsive induction of urease expression in Helicobacter pylori is mediated at the transcriptional level. Infect. Immun.69:4891-4897.
  • 656. van Vliet, A. H. M., S. W. Poppelaars, B. J. Davies, J. Stoof, S. Bereswill, M. Kist, C. W. Penn, E. J. Kuipers, and J. G. Kusters. 2002. NikR mediates nickel-responsive transcriptional induction of urease expression in Helicobacter pylori. Infect. Immun.70:2846-2852.
  • 657. van Vliet, A. H. M., J. Stoof, S. W. Poppelaars, S. Bereswill, G. Homuth, M. Kist, E. J. Kuipers, and J. G. Kusters. 2003. Differential regulation of amidase- and formamidase-mediated ammonia production by the Helicobacter pylori Fur repressor. J. Biol. Chem.278:9052-9057. [[PubMed]
  • 658. van Vliet, A. H. M., J. Stoof, R. Vlasblom, S. A. Wainwright, N. J. Hughes, D. J. Kelly, S. Bereswill, J. J. Bijlsma, T. Hoogenboezem, C. M. Vandenbroucke-Grauls, M. Kist, E. J. Kuipers, and J. G. Kusters. 2002. The role of the ferric uptake regulator (Fur) in regulation of Helicobacter pylori iron uptake. Helicobacter7:237-244. [[PubMed]
  • 659. van Vliet, A. H. M., F. D. Ernst, and J. G. Kusters. 2004. NikR-mediated regulation of Helicobacter pylori acid-adaptation. Trends Microbiol.12:489-494. [[PubMed]
  • 660. Velayudhan, J., N. J. Hughes, A. A. McColm, J. Bagshaw, C. L. Clayton, S. C. Andrews, and D. J. Kelly. 2000. Iron acquisition and virulence in Helicobacter pylori: a major role for FeoB, a high-affinity ferrous iron transporter. Mol. Microbiol.37:274-286. [[PubMed]
  • 661. Veldhuyzen van Zanten, SJ. 1995. Do socio-economic status, marital status and occupation influence the prevalence of Helicobacter pylori infection? Aliment. Pharmacol. Ther.9(Suppl. 2):41-44. [[PubMed][Google Scholar]
  • 662. Veldhuyzen van Zanten, S. O. J., M. F. Dixon, and A. Lee. 1999. The gastric transitional zones: neglected links between gastroduodenal pathology and Helicobacter ecology. Gastroenterology116:1217-1229. [[PubMed]
  • 663. Velin, D., D. Bachmann, H. Bouzourene, and P. Michetti. 2005. Mast cells are critical mediators of vaccine-induced Helicobacter clearance in the mouse model. Gastroenterology129:142-155. [[PubMed]
  • 664. Verdú, E., D. Armstrong, R. Fraser, F. Viani, J.-P. Idström, C. Cederberg, and A. L. Blum. 1995. Effect of H. pylori status on intragastric pH during treatment with omeprazole. Gut36:539-543.
  • 665. Verhoef, C., R. G. Pot, R. A. de Man, P. E. Zondervan, E. J. Kuipers, J. N. Ijzermans, and J. G. Kusters. 2003. Detection of identical Helicobacter DNA in the stomach and in the non-cirrhotic liver of patients with hepatocellular carcinoma. Eur. J. Gastroenterol. Hepatol.15:1171-1174. [[PubMed]
  • 666. Viala, J., C. Chaput, I. G. Boneca, A. Cardona, S. E. Girardin, A. P. Moran, R. Athman, S. Memet, M. R. Huerre, A. J. Coyle, P. S. DiStefano, P. J. Sansonetti, A. Labigne, J. Bertin, D. J. Philpott, and R. L. Ferrero. 2004. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol.5:1166-1174. [[PubMed]
  • 667. Vincent, P., F. Gottrand, P. Pernes, M. O. Husson, M. Lecomtehoucke, D. Turck, and H. Leclerc. 1994. High prevalence of Helicobacter pylori infection in cohabiting children—epidemiology of a cluster, with special emphasis on molecular typing. Gut35:313-316.
  • 668. Vogt, K., M. Warrelmann, and H. Hahn. 1989. The minimum inhibitory concentrations of various bismuth salts against Campylobacter pylori. Zentbl. Bakteriol.271:304-308. [[PubMed]
  • 669. Voland, P., M. Zeitner, N. Hafsi, and C. Prinz. 2006. Human immune response towards recombinant Helicobacter pylori urease and cellular fractions. Vaccine24:3832-3839. [[PubMed]
  • 670. Wada, A., E. Yamasaki, and T. Hirayama. 2004. Helicobacter pylori vacuolating cytotoxin, VacA, is responsible for gastric ulceration. J. Biochem. (Tokyo)136:741-746. [[PubMed]
  • 671. Waidner, B., S. Greiner, S. Odenbreit, H. Kavermann, J. Velayudhan, F. Stahler, J. Guhl, E. Bisse, A. H. M. van Vliet, S. C. Andrews, J. G. Kusters, D. J. Kelly, R. Haas, M. Kist, and S. Bereswill. 2002. Essential role of ferritin Pfr in Helicobacter pylori iron metabolism and gastric colonization. Infect. Immun.70:3923-3929.
  • 672. Waidner, B., K. Melchers, I. Ivanov, H. Loferer, K. W. Bensch, M. Kist, and S. Bereswill. 2002. Identification by RNA profiling and mutational analysis of the novel copper resistance determinants CrdA (HP1326), CrdB (HP1327), and CzcB (HP1328) in Helicobacter pylori. J. Bacteriol.184:6700-6708.
  • 673. Walsh, E. J., and A. P. Moran. 1997. Influence of medium composition on the growth and antigen expression of Helicobacter pylori. J. Appl. Microbiol.83:67-75. [[PubMed]
  • 674. Walz, A., S. Odenbreit, J. Mahdavi, T. Boren, and S. Ruhl. 2005. Identification and characterization of binding properties of Helicobacter pylori by glycoconjugate arrays. Glycobiology15:700-708. [[PubMed]
  • 675. Wang, G., R. C. Conover, S. Benoit, A. A. Olczak, J. W. Olson, M. K. Johnson, and R. J. Maier. 2004. Role of a bacterial organic hydroperoxide detoxification system in preventing catalase inactivation. J. Biol. Chem.279:51908-51914. [[PubMed]
  • 676. Wang, G., and R. J. Maier. 2004. An NADPH quinone reductase of Helicobacter pylori plays an important role in oxidative stress resistance and host colonization. Infect. Immun.72:1391-1396.
  • 677. Wang, G., A. A. Olczak, J. P. Walton, and R. J. Maier. 2005. Contribution of the Helicobacter pylori thiol peroxidase bacterioferritin comigratory protein to oxidative stress resistance and host colonization. Infect. Immun.73:378-384.
  • 678. Wang, G., D. A. Rasko, R. Sherburne, and D. E. Taylor. 1999. Molecular genetic basis for the variable expression of Lewis Y antigen in Helicobacter pylori: analysis of the alpha-(1,2)-fucosyltransferase gene. Mol. Microbiol.31:1265-1274. [[PubMed]
  • 679. Wang, H. J., C. H. Kuo, A. A. Yeh, P. C. Chang, and W. C. Wang. 1998. Vacuolating toxin production in clinical isolates of Helicobacter pylori with different vacA genotypes. J. Infect. Dis.178:207-212. [[PubMed]
  • 680. Wang, J., E. G. Brooks, K. B. Bamford, T. L. Denning, J. Pappo, and P. B. Ernst. 2001. Negative selection of T cells by Helicobacter pylori as a model for bacterial strain selection by immune evasion. J. Immunol.167:926-934. [[PubMed]
  • 681. Wang, T. C., C. A. Dangler, D. Chen, J. R. Goldenring, T. Koh, R. Raychowdhury, R. J. Coffey, S. Ito, A. Varro, G. J. Dockray, and J. G. Fox. 2000. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology118:36-47. [[PubMed]
  • 682. Wang, T. C., and J. G. Fox. 1998. Helicobacter pylori and gastric cancer: Koch's postulates fulfilled? Gastroenterology115:780-783. [[PubMed]
  • 683. Ward, J. M., M. R. Anver, D. C. Haines, and R. E. Benveniste. 1994. Chronic active hepatitis in mice caused by Helicobacter hepaticus. Am. J. Pathol.145:959-968.
  • 684. Ward, J. M., M. R. Anver, D. C. Haines, J. M. Melhorn, P. Gorelick, L. Yan, and J. G. Fox. 1996. Inflammatory large bowel disease in immunodeficient mice naturally infected with Helicobacter hepaticus. Lab. Anim. Sci.46:15-20. [[PubMed]
  • 685. Ward, J. M., J. G. Fox, M. R. Anver, D. C. Haines, C. V. George, M. J. Collins, Jr., P. L. Gorelick, K. Nagashima, M. A. Gonda, R. V. Gilden, et al. 1994. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J. Natl. Cancer Inst.86:1222-1227. [[PubMed]
  • 686. Warren, J. R., and B. J. Marshall. 1983. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lanceti:1273-1275. [[PubMed]
  • 687. Watanabe, T., M. Tada, H. Nagai, S. Sasaki, and M. Nakao. 1998. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology115:642-648. [[PubMed]
  • 688. Weeks, D. L., S. Eskandari, D. R. Scott, and G. Sachs. 2000. A H+-gated urea channel: the link between Helicobacter pylori urease and gastric colonization. Science287:482-485. [[PubMed]
  • 689. Weeks, D. L., and G. Sachs. 2001. Sites of pH regulation of the urea channel of Helicobacter pylori. Mol. Microbiol.40:1249-1259. [[PubMed]
  • 690. Wen, Y., E. A. Marcus, U. Matrubutham, M. A. Gleeson, D. R. Scott, and G. Sachs. 2003. Acid-adaptive genes of Helicobacter pylori. Infect. Immun.71:5921-5939.
  • 691. Werdmuller, B. F. M., and R. J. L. F. Loffeld. 1997. Helicobacter pylori has no role in the pathogenesis of reflux esophagitis. Dig. Dis. Sci.42:103-105. [[PubMed]
  • 692. Westblom, T. U., E. Madan, and B. R. Midkiff. 1991. Egg yolk emulsion agar, a new medium for the cultivation of Helicobacter pylori. J. Clin. Microbiol.29:819-821.
  • 693. Willhite, D. C., and S. R. Blanke. 2004. Helicobacter pylori vacuolating cytotoxin enters cells, localizes to the mitochondria, and induces mitochondrial membrane permeability changes correlated to toxin channel activity. Cell. Microbiol.6:143-154. [[PubMed]
  • 694. Wirth, H. P., M. H. Beins, M. Yang, K. T. Tham, and M. J. Blaser. 1998. Experimental infection of Mongolian gerbils with wild-type and mutant Helicobacter pylori strains. Infect. Immun.66:4856-4866.
  • 695. Wong, B. C., S. K. Lam, W. M. Wong, J. S. Chen, T. T. Zheng, R. E. Feng, K. C. Lai, W. H. Hu, S. T. Yuen, S. Y. Leung, D. Y. Fong, J. Ho, C. K. Ching, J. S. Chen, and the C.G.C.S. Group. 2004. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA291:187-194. [[PubMed]
  • 696. Woodward, M., C. Morrison, and K. McColl. 2000. An investigation into factors associated with Helicobacter pylori infection. J. Clin. Epidemiol.53:175-181. [[PubMed]
  • 697. Worst, D. J., M. M. Gerrits, C. M. J. E. Vandenbroucke-Grauls, and J. G. Kusters. 1998. Helicobacter pylori ribBA-mediated riboflavin production is involved in iron acquisition. J. Bacteriol.180:1473-1479.
  • 698. Wu, M. S., L. T. Chen, C. T. Shun, S. P. Huang, H. M. Chiu, H. P. Wang, M. T. Lin, A. L. Cheng, and J. T. Lin. 2004. Promoter polymorphisms of tumor necrosis factor-alpha are associated with risk of gastric mucosa-associated lymphoid tissue lymphoma. Int. J. Cancer110:695-700. [[PubMed]
  • 699. Wu, M. S., C. Y. Wu, C. J. Chen, M. T. Lin, C. T. Shun, and J. T. Lin. 2003. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int. J. Cancer104:617-623. [[PubMed]
  • 700. Wundisch, T., C. Thiede, A. Morgner, A. Dempfle, A. Gunther, H. Liu, H. Ye, M. Q. Du, T. D. Kim, E. Bayerdorffer, M. Stolte, and A. Neubauer. 2005. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J. Clin. Oncol.23:8018-8024. [[PubMed]
  • 701. Xiao, S. D., W. Z. Liu, D. H. Xia, S. J. Jiang, R. N. Wang, Z. H. Zhang, and W. W. Xu. 1990. The efficacy of furazolidone and metronidazole in the treatment of chronic gastritis associated with Helicobacter (Campylobacter) pylori—a randomized double-blind placebo-controlled clinical trial. Hepato-Gastroenterology37:503-506. [[PubMed]
  • 702. Xu, Q., R. D. Morgan, R. J. Roberts, S. Y. Xu, L. J. van Doorn, J. P. Donahue, G. G. Miller, and M. J. Blaser. 2002. Functional analysis of iceA1, a CATG-recognizing restriction endonuclease gene in Helicobacter pylori. Nucleic Acids Res.30:3839-3847.
  • 703. Yamamoto, K., K. Hirao, T. Oshima, H. Aiba, R. Utsumi, and A. Ishihama. 2005. Functional characterization in vitro of all two-component signal transduction systems from Escherichia coli. J. Biol. Chem.280:1448-1456. [[PubMed]
  • 704. Yamaoka, Y., S. Kikuchi, H. M. el-Zimaity, O. Gutierrez, M. S. Osato, and D. Y. Graham. 2002. Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology123:414-424. [[PubMed]
  • 705. Yamaoka, Y., M. Kita, T. Kodama, S. Imamura, T. Ohno, N. Sawai, A. Ishimaru, J. Imanishi, and D. Y. Graham. 2002. Helicobacter pylori infection in mice: role of outer membrane proteins in colonization and inflammation. Gastroenterology123:1992-2004. [[PubMed]
  • 706. Yamaoka, Y., T. Kodama, O. Gutierrez, J. G. Kim, K. Kashima, and D. Y. Graham. 1999. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J. Clin. Microbiol.37:2274-2279.
  • 707. Yamaoka, Y., D. H. Kwon, and D. Y. Graham. 2000. A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc. Natl. Acad. Sci. USA97:7533-7538.
  • 708. Yamaoka, Y., J. Souchek, S. Odenbreit, R. Haas, A. Arnqvist, T. Boren, T. Kodama, M. S. Osato, O. Gutierrez, J. G. Kim, and D. Y. Graham. 2002. Discrimination between cases of duodenal ulcer and gastritis on the basis of putative virulence factors of Helicobacter pylori. J. Clin. Microbiol.40:2244-2246.
  • 709. Yamazaki, S., A. Yamakawa, Y. Ito, M. Ohtani, H. Higashi, M. Hatakeyama, and T. Azuma. 2003. The CagA protein of Helicobacter pylori is translocated into epithelial cells and binds to SHP-2 in human gastric mucosa. J. Infect. Dis.187:334-337. [[PubMed]
  • 710. Yea, S. S., Y. I. Yang, W. H. Jang, Y. J. Lee, H. S. Bae, and K. H. Paik. 2001. Association between TNF-alpha promoter polymorphism and Helicobacter pylori cagA subtype infection. J. Clin. Pathol.54:703-706.
  • 711. Yokota, K., Y. Kurebayashi, Y. Takayama, S. Hayashi, H. Isogai, E. Isogai, K. Imai, T. Yabana, A. Yachi, and K. Oguma. 1991. Colonization of Helicobacter pylori in the gastric mucosa of Mongolian gerbils. Microbiol. Immunol.35:475-480. [[PubMed]
  • 712. Yoshiyama, H., and TNakazawa. 2000. Unique mechanism of Helicobacter pylori for colonizing the gastric mucus. Microbes Infect.2:55-60. [[PubMed][Google Scholar]
  • 713. You, W. C., J. Y. Hong, L. Zhang, K. F. Pan, D. Pee, J. Y. Li, J. L. Ma, N. Rothman, N. Caporaso, J. F. Fraumeni, Jr., G. W. Xu, and M. H. Gail. 2005. Genetic polymorphisms of CYP2E1, GSTT1, GSTP1, GSTM1, ALDH2, and ODC and the risk of advanced precancerous gastric lesions in a Chinese population. Cancer Epidemiol. Biomarkers Prev.14:451-458. [[PubMed]
  • 714. Young, V. B., K. A. Knox, J. S. Pratt, J. S. Cortez, L. S. Mansfield, A. B. Rogers, J. G. Fox, and D. B. Schauer. 2004. In vitro and in vivo characterization of Helicobacter hepaticus cytolethal distending toxin mutants. Infect. Immun.72:2521-2527.
  • 715. Zagari, R. M., F. Bazzoli, P. Pozzato, S. Fossi, L. De Luca, G. Nicolini, D. Berretti, and E. Roda. 1999. Review article: non-invasive methods for the diagnosis of Helicobacter pylori infection. Ital. J. Gastroenterol. Hepatol.31:408-415. [[PubMed]
  • 716. Zambon, C. F., D. Basso, F. Navaglia, C. Belluco, A. Falda, P. Fogar, E. Greco, N. Gallo, M. Rugge, F. Di Mario, and M. Plebani. 2005. Pro- and anti-inflammatory cytokine gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine29:141-152. [[PubMed]
  • 717. Zambon, C. F., D. Basso, F. Navaglia, G. Germano, N. Gallo, M. Milazzo, E. Greco, P. Fogar, S. Mazza, F. Di Mario, G. Basso, M. Rugge, and M. Plebani. 2002. Helicobacter pylori virulence genes and host IL-1RN and IL-1beta genes interplay in favouring the development of peptic ulcer and intestinal metaplasia. Cytokine18:242-251. [[PubMed]
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.